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BACTERIOLOGICAL PROFILE OF DIABETIC FOOT AMONG THE PATIENT
ATTENDING TERTIARY CARE HOSPITAL IN KULASEKHARAM.
ABSTRACT
Introduction: Diabetic foot is a major medical problem worldwide leading to
disability.
Aims ad objectives: To determine the bacterial profiles of infected diabetic foot
ulcers and the antibiotic sensitivity pattern of the isolates.
Materials and Methods: Samples were collected from 75 patients with diabetic foot
ulcers by using sterile swabs, aspirated pus and debridement tissue and they were
processed.
Results: The age group of these patients ranged from 41 to 90 years and the maximum
number of patients was in the age group of 51 to 70 years. Gram negative bacilli were
more predominant (73.8%) and the Gram positive cocci (26.2%). Out of 107 isolates,
70 Gram negative bacilli and 20 gram positive cocci were isolated in the age group of
51 to 70. Pseudomonas species was the predominant isolate followed by Klebsiella
species, Proteus species, E.coli, Citrobacter species, Acinetobacter species and
Enterobacter species. Among the Gram positive cocci isolated in this age group (51 to
70years) Staphylococcus aureus was predominant. In most of the infections in the age
group between 51 to 70 years was polymicrobial (31 cases). Gram negative and Gram
positive organisms were highly sensitive to Netilmicin (76% and 81%). Sensitivity to
Amikacin was (59% and 73%). Extended Spectrum Beta Lactamase (ESBL)
producing organisms were mainly seen in E.coli (67%), Klebsiella (47%).
Conclusion: Diabetic foot ulcer infection should be treated according to culture and
sensitivity report. Diabetic foot ulcer treatment should be based on Multidisciplinary
approach.
Key words: Extended Spectrum Beta Lactamase, Diabetic foot, Methicillin Resistant
Staphylococcus aureus, Coagulase negative Staphylococcus aureus.
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INTRODUCTION 
Diabetes mellitus is a metabolic disorder characterized by chronic  
hyperglycemia and about 150- 170 million people are suffering worldwide 
from this diseases, as per WHO reports the prevalence of diabetes will be 
double by 2025. Diabetes mellitus is a worldwide phenomenon, type 2 
diabetes is the most common   form of diabetes in developing countries like 
India, hence called diabetic capital of  the world. In India prevalence of 
diabetes in rural population is about 2.4 %, and in urban population is about 4-
11.6 %. Complications of diabetes mellitus are peripheral vascular disease, 
cardiovascular disease, nephropathy, retinopathy, neurological and infections.  
Uncontrolled hyperglycemia, atherosclerotic vascular disease, sensory 
neuropathy are the most important risk factors developing diabetic foot ulcer .
1 
Twenty five percent diabetic patients have a risk of  developing foot 
ulcer and limp amputation was 15- 45% higher than non diabetic ulcer.
2 
PATHOGENESIS: 
For development of diabetic foot ulcer, the most important risk factors 
are peripheral neuropathy and impaired blood circulation from peripheral 
vascular disease 
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Neuropathy: 
              Development of neuropathy is as a result of hyperglycemia induced 
metobolic disorder. The  most important one is polyol pathway. 
Hyperglycemia state  willfavour aldose reductase and sorbitol dehydrogenase  
which will convert intracellular glucose to sorbitol and fructose and due to the 
accumulation of these sugar products  leads to decrease in the synthesis of 
myoinositol, which  is needed for normal neuron conduction . The   
conversion of glucose  leads to depletion of nicotinamide adenine dinucleotide 
phosphate  which is required for detoxification of reactive oxygen species and 
for synthesis of vasodilator nitric oxide. This leads to oxidative stress on nerve 
cells and  increase vasoconstricton  leads to is chaemia, which will result in 
nerve cell injury and death. This also contributes to abnormal glycation of 
nerve cells and leads to inappropriate action  of  protein kinase C and leads to 
further nerve damage. 
In diabetic patients neuropathy develops in motor ,sensory ,autonomic    
components of nervous system. Imbalance between flexion and extension due 
to damage of innervations of  intrinsic foot muscles ,leads to foot deformities 
that create abnormal bony prominence and pressure points ,which  favour for 
skin break down  and ulceration. 
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Autonomic neuropathy leads to suppression of the function of sweat 
and oil gland. Foot loses natural function of the moisturising the skin and 
becomes dry which leads to breakdown and gradually develops  infection. 
Sensory neuropathy wounds are unnoticed by the patients which 
worsenes and exacerbates the development of ulcer.   
Vascular disease: 
The persistent hyperglycemic state leads to  endothelial cell dysfunction 
and smooth cell abnormalities  in peripheral arteries  which result in the 
decrease of endothelium derived vasodilator that leads to vasoconstriction . 
The  diabetes hyperglycemic state  leads to increase in thromboxane A2, a 
vasoconstrictor, platelet aggregation which promote the risk for hyper 
coagulability, and alteration in the vascular extra cellular matrix  leads arterial 
lumen stenosis. The other factors like smoking, hypertension , hyperlipidemia 
contribute to the development of peripheral arterial disease.
3
 
Pathophysiology: In diabetes patients altered protein and lipid 
metabolism leads to defective wound healing process. Increased glucose level 
in the body end up in uncontrolled covalent bonding aldose sugars to a lipid or 
protein without any normal glycosylation enzyme. This product accumulate on 
surface of cell membranes, Circulating proteins and structural proteins and this 
product is called as advanced glycation end product (AGE). Formation of 
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AGE  products occurs on extra cellular matrix protein with slow turn  over 
rate. AGE products  alter the properties of matrix protein such as laminin, 
collagen and vitronectin through intermolecular cross linking or covalent 
bonding of AGE  products. AGE  products also cross link  elastin type on 
collagen that leads to increased stiffness and increased synthesis of type III 
collagen that forms the granulation tissue. AGE on laminin result in reduced 
binding to type IV collagen in the basement membrane, reduced binding of 
heparin sulphate proteoglyconand  polymer elongation. 
Nitric oxide is a stimulator of cell maturation, proliferation and 
differentiation and increases fibroblast proliferation and thereby collagen 
production in wound healing. Nitric oxide and L-arginine are needed for  
proper  cross linking of collagen fibres via prolene to maximize the tensile 
strength and minimise the scaring of healed tissues. Pulsatile flow of blood 
through vessels will activate endothelial cell specific nitric oxide synthase 
(EcNOS). Nitric oxide is produced by endothelial cell specific nitric oxide 
synthase, maintains the proper blood flow to tissues and diameter of blood 
vessels and also regulates angiogenesis, which plays an important role in 
wound healing. The diabetic patients reduced ability to produce nitric oxide 
from L-arginine, due to high glucose associated kidney dysfuction 
ketoacidosis. results in accumulation of nitric oxide synthase inhibitor that 
leads to reduced production of nitric oxide synthase and pH dependent nature 
of nitric oxide synthase.
4
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Diabetic ulcer fibroblasts show various morphological differences, that 
usually large and widely spread in the culture flask, compared to the spindle 
shaped morphology of the fibroblast in the age matched controls. They often 
show numerous vesicular bodies, dialated endoplasmic reticulum and lack of 
micro tubular structure. Interpretations of this observations would be that 
inspite of high protein turn over and production in diabetic ulcer fibroblasts, 
vesicles containing secretory proteins  could not travel along the micro tubules 
to release the products outside. Diabetic ulcer fibroblasts exhibit proliferative 
impairment that contributes to a decreased production of extracellular matrix 
proteins and delayed wound contraction and impaired wound healing. For 
wound healing, extra cellular matrix not only needs to be lay down and also 
able to undergo remodeling and degradation to develop a mature tissue with 
appropriate tensile strength.
5
 
Past twenty years major increase in mortality among the diabetic people 
is considered to be due to micro and macro vascular complication. Wound 
healing process is a step wise repair of last extra cellular matrix (ECM) that 
develop the largest component of the dermal skin layer. To avoid over or 
under healing, accurate control and rebuilding is essential ortherwise it may 
lead to various abnormalities. But in some situation the physiological insult 
and certain metabolic disorders that impedes the normal steps of the wound 
healing mechanism. One of the examples of metabolic disorder is diabetes 
mellitus. Many histopathological studies have shown the prolonged 
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inflammatory phase in diabetic wound ulcer which leads to delay in the 
formation of mature granulation tissue and reduction in wound tensile 
strength. Non healing chronic diabetic ulcers are often treated with 
extracellular matrix replacement therapy, advanced moist wound therapy, 
negative pressure wound therapy, bio engineered skin or tissue substitute, 
growth factors. No therapy is completely perfect as each have their own 
disadvantages. Moist wound therapy stimulates keratinocyte and proliferation 
and migration, early angiogenesis, collagen synthesis and wound contraction. 
Various categories of moist dressings are adhesive, backing film, silicon 
coated foam, hydrocolloids and hydro gels etc. Moist wound dressing is not 
the best for exudative wounds because it causes fluid retention. In diabetic 
ulcer treatment various tissue engineering technologies have come up with a 
cellular or cellular skin replacement products. New therapies such as platelet 
rich fibrin wound patch which is effective in chronic diabetic ulcer.
6
 
Assessment of  diabetic  foot ulcers 
In 2008 American Diabetes Association  of the foot  care interested 
group recommended components of  foot examinations for patients with 
diabetes;  
1. Visual inspection of bare foot should be performed in a well – lit room . 
2. Should include assessment of shoes – inappropriate foot wear leads to 
ulcer . 
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3. Should check between the toes for the presence of ulceration or signs of 
infection . 
4. The  presence of callus or nail abnormality should be noted . 
5. Temperature difference between feet – suggestive of vascular disease. 
6. The foot should also be examined for deformities . 
7. To palpate the dorsalispedis and posterior tibial pulses and  
characterized as present or absent to asses vascular disease .    
Wagner ulcer classification : 
               Grade                       Ulcer  
                    0 No open lesion ,skin  intact   
                     1 Superficial diabetic  ulcer 
                     2 Ulcer involves ligament , tendon ,joint capsule  or fascia  
                     3 Grade 2 ulcer with abscess or osteomyelitis  
                     4 Partial fore foot gangrene  
                     5 Extensive foot gangrene.
7
 
            In diabetes mellitus patients, one of the major complications is diabetic 
ulcer. Fifteen percent  diabetes mellitus patients develop diabetic foot ulcer 
and leads to 84% of foot amputation.
8
 
The present study was carried out  to determine  the aerobic  bacterial 
isolates cultured from diabetic foot infections and their susceptibility to 
commonly used antibiotics.           
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AIMS AND OBJECTIVES 
1. To determine the bacterial profiles of infected diabetic foot ulcers and  
2. To determine the antibiotic sensitivity pattern of the isolates. 
Review of Literature  
 
 
9 
 
REVIEW OF LITERATURE 
In 1973, Burkitt.D.P et al said that diabetes mellitus was  a global 
burden. Key factors for development of diabetes are environmental socio 
economical and metabolic. Complications of diabetes such as neuropathy is to 
unbalance glycemia level and is associated with other diseases such as 
depression and artheroscelerosis.
9
 
In 1984 Sapico F.L et al said that, diabetic foot infections are treated 
empirically  according to causative microorganisms may improve the patient 
outcome. When optimal sample collection, transport, and culture techniques 
are used multiple organisms are isolated from diabetic foot infections. 
Interactions  of organisms within these polymicrobial mixture leads to 
production of virulence factors such as collagenases, hemolysins , proteases 
and short chain fatty acids ,that cause inflamation, impede wound healing and 
leads to chronicity of infection .
10
 
In 1992 Brike J.A et al said that in india type 2 diabetes is the most 
common and 31.7million    people are diabetics in India. Complications of 
diabetes include peripheral neuropathy, nephropathy, retinopathy, 
cardiovascular disease, diabetic foot, hypertension, cerebrovascular disease. In 
diabetic patients many factors like trauma ,smoking ,durations of diabetes, 
deformity can cause ulcer in foot ,however neuropathy, peripheral vascular 
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disease are the two major factors for developing the foot ulcer. Due to these 
risk factors ,untreated minor abrasions can cause foot ulcer,  further  can get 
infection with  aerobic and  anaerobic bacteria. With the help of broad 
spectrum antibiotics and proper foot care may help in healing the ulcer .If at 
any point of delay may lead to complications like amputation of foot or limp.
11
 
In 1994 Caputo.GM et al, observed that in India 33 million people are 
diabetics which was highest in the world, out of which nearly 15% suffer from 
the dreaded sequelae of diabetic foot. Certain types of infections are common 
in diabetics and others more severe. It is not only the numbers that is 
worrisome, situation is different in India due to socio cultural practices as 
barefoot walking, religious practices like walking on fire, use of improper foot 
wear and lack of knowledge about foot care attributes towards increase in the 
prevalence of diabetic foot. Diabetic foot ulcers are not spontaneous ulcers, 
but results from the interplay of various factors like peripheral vascular 
disease, neuropathy, autonomic neuropathy, alteration in the plantar pressure, 
limited joint mobility and defective foot wear. Cell mediated immunity is 
mostly affected with abnormalities of polymorphonuclear leukocytes (PMN), 
monocytes and lymphocytes. There are abnormalities of adherence, 
chemotaxis, phagocytosis, oxidative burst and intracellular killing, also 
advanced glycation and products leads to the state of low level persistent 
activation in polymorphonuclear cells, which leads to spontaneous activation 
of the oxidative burst and the release of myeloperoxidase, elastase and other  
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neutrophil granular components which may lead to burn out or tolerant 
polymorphonuclear leucocytes, also may initiate pathologic process leading to 
vascular injury. Adapting cellular immunity is also affected with decreased 
lymphocyte proliferative response.
12
 
 In 1994, Foster.AVM et al, said that in diabetic wound case 
management, selection of dressing is also important component, specific 
dressing types could prove beneficial depending on the characteristics of the 
individual wound. For example saline soaked gauze dressings were 
inexpensive, well tolerated, atraumatic, moist wound environment. Foam and 
alignate dressings are highly absorbant and decreasing the risk for maceration 
in wounds with heavy exudates. However, an ideal dressing should contribute 
to a moist wound environment, absorb excessive exudates which increase the 
risk for infections.
13
 
 In 1995 Steed D, discussed  the  adjunctive wound care treatment were 
under investigation and in practice for diabetic foot ulcer. With the help of 
human skin equivalents had been shown to promote wound healing in diabetic 
ulcers, through the action of cytokines and dermal matrix components , which 
will stimulate tissue growth and wound closure . A recombinant platelet 
derived growth factor was also currently in use . Other adjunctive therapies 
were hyperbaric oxygen therapy (HBOT) and granulocyte colony stimulating 
factors .HBOT  is the delivery of oxygen at higher than atmospheric pressure 
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to the patients, which leads to increase oxygen concentration level in the 
blood, increase diffusion capacity to the tissues and also increase partial 
pressure of oxygen in the tissues, which stimulates neovascularization , 
fibroblast replication, increase phagocytosis and leukocyte mediated killing of 
bacterial pathogens in the wound.
14
 
 In 1995, Reiber.G E et al, had  detected that lower extremity 
amputation was the most feared complication of diabetes, in many cases 
amputation should be a treatment option, with good rehabilitation patient may 
return to normal activities. However,  in countries like Poland  the supporting 
mechanism for amputees are not well developed. Amputation should be 
considered in very limited situations. One of the indications for amputation is 
serious infection which could be life threatening sepsis. As reconstruction 
cannot be performed in ischaemic limb, amputation is considered. And also 
the amputation is also considered in significant rest pain which was not 
manageable with analgesics.In a major amputation subsequent outcome of the 
patient was poor. In 5 years, the mortality rate was as high as 40% to 70%. 
The multidisciplinary team approach to diabetic foot has been shown as a 
major reduction in amputation incidence.
15
 
In 1995, Gerding.DN, said that anerobes are often participate in a 
mixed infections with aerobes, especially  in deep tissue infection. But they 
are rarely as sole pathogen. Less virulent bacteria coagulase negative 
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staphylococcus species, enterococcus species or corynebacterium species are 
also represent as true pathogens.
16
 
In 1995, Armstrong.D.G et al, said that the role of anerobes is 
particularly unclear  because in many studies, samples were not collected 
appropreiately for anaerobic culture or due to lack of anaerobic setup in many 
institutions. Among those who did with appropriate methods, some reports 
that anaerobes play a minimal role, while others have detected 95% prevalence 
of anaerobes, in a study with Bacteroidesfragilis being the predominant 
anaerobe isolated.
17 
In 1996, Baird.D et al, identified that diabetic foot ulcer infections are 
mostly polymicrobial infections, proper management of these infections 
requires an appropriate antibiotic solution based on the culture and 
antimicrobial sensitivity testing results.
18 
In 1997, Stone.J.A et al reported that uncontrolled diabetes is prone to 
skin infections, increased blood sugar levels thatleads to inhibit bacteria 
fighting cell. Skin infections may be hazadours, even small injury may 
progress to ulcer if not properly treated.
19
 
In 1997, Boyko.E.J et al, said that hyperglycemia in diabetes mellitus 
further alters cellular function, damage endothelium of vessel valve and 
further plaque formation and narrowing of vessels. In people with diabetes,  
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the effect of  atherosclerosis is as high as 2 to 3 times and calf vessels were 
most affected. Peripheral vascular disease may lead to poor healing and 
increased risk for amputation. Ischaemia presents as bilateral absence of pedal 
pulses and claudication pain. To assess   the  ischaemia, posterior tibial and 
dorsalispedis arteries pulses should be palpated and also to collect the history 
of claudication pain. Colour also may be assessed which may be difficult in 
dark skin, pale on elevation or  rubor on  dependency may indicate ischaemia. 
Other characteritics were skin temperature (cold on touch), capillary refill 
more than six seconds, dry, fissured skin, absence of hair growth, dystrophic 
toe nails, presence of oedema, pain or dry gangrene. 
20
 
In 1998, Smith.D et al evaluated that diabetic foot ulceration become 
infected approximately 56%. Signs of infections were cellulitis, increase in 
local temperature, foul smell, oedema, abscess formation. Due to neuropathy 
the pain is absent. Leucocytosis, fever may not be present in about 50% 
diabetic patients. Infection may be caused by gram negative, gram positive 
bacteria and anaerobes. Short time duration of ulcers were usually infected by 
single gram positive organism, but chronic ulcers may yield mixed flora, both 
gram positive and gram negative organisms may be with anaerobes.
21
 
In 1998, Armstrong.D.G et al, said that risk factors for ulcer 
development were trauma and pressure. It may be necessary to encourage the 
no weight strategies such as walker, bed rest, wheel chair and 
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crutches.Encourage the patient to replace or modify their foot wear. Custom 
made shoe inserts (orthoses) may be necessary for pressure reduction or 
redistribution. Selection of devices mustbe  taken into consideration that the 
ability of device to remove pressure, ease of application, cost effectiveness and 
ability to gain patient compliance. 
22
 
In 1998 Reiber G.E et al suggested platelet rich fibrin therapy for 
chronic or hard to treat diabetic ulcers. Isolation  fibrin or plasma from the 
patients blood ,which have rich platelets and growth factors to promote natural 
healing process. Application of these product to diabetic foot ulcers have been 
shown to accelerate healing. Leucopatch is one such product which is a three 
layered fibrin patch. It is composed of patients own cells and growth factor 
,containing high level of platelets and leukocytes.  After six weeks of 
treatment with Lekopatch application showed significant reduction of wound 
area (65%).
23
 
In 1998, Pathare.N.A et al, had described that dibetes mellitus is one 
of the major health problem in world and in India around eighty million 
people were diabetic. Asia is contributing more than 60% of worlds population 
with diabetes. India and China contritubes the largest. Incident of multidrug 
resistant bacteria has been increased in recent years which leads to increased 
hospital stay, morbidity, mortality and costs. Diabetic foot infections were 
polymicrobial, usually mixed organism but the organisms depends on other 
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factors such as microbial flora of the lower limb, foot hygiene, metabolic 
factors and use of antibiotics.
24
 
In 1998, Krasner.D et al proved that neuropathic ulcer, primarily seen 
on the plantar aspect of the foot at the base of the metatarsal heads and first 
and fifth base of the toe. Ischaemic ulcer mostly occur as distal lesions on the 
toe or back of the heal.
25
 
In 1998, Lovery.L.A et al, said that in diabetic patients, once ulcer has 
developed, risk of wound progression is increased, that may ultimately leads 
to amputation in up to 85% patients of diabetic ulceration may require 
amputation. Team approach to wound care, can prevent at least 40% of 
amputation in diabetic patients.
26
 
In 1999, Reiber et al, said that factorswhich may affect wound healing 
are as follows: wound environment, vascular status, ischaemia, pressure area, 
glycemic control and nutrition status. Comorbidities, retinopathy, end stage 
renal disease, hypertension, history of amputation and some medications are 
also involved in blood glucose control and peripheral vascular disease.
27
 
 In 1999, Kelwin.W.S et al, said that in diabetic foot on average of 5 to 
6 strains of organisms are often involved with mixture of aerobic and 
anaerobic organisms.
28
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              In 1999, Zangaro.G.A et al, discussed about examination of foot 
wear, because 55% of traumatic events were result of poorly fitting shoes, 
health care providers and clients must be able to assess the appropriateness of 
foot wear. The type of shoe, pattrern of wear,fit,linings,seams,insoles or 
orthoses and presence of foreign bodies must be assessed and appropriate 
intervention implemented. When choosing shoes, clients are advised to shop 
late in the day and to be measured both feet.  Shoes should be sufficiently 
ideal with a deep toe box to accommodate foot changes or deformities. Laces 
were preferred to accommodate swelling, natural fibers such as soft leather 
more readily conform to the foot and non skid soles and low heals reduce the 
risk of falls.
29
 
In 1999, Lipsky. BA identified that Staphylococcus aureus and beta 
haemolytic streptococci are the first microorganisms to colonise and infect the 
skin. Patients with previously treated or with chronic infections, gram negative 
bacilli mainly Enterobacteriaceae was found. Wounds treated with wet 
dressing the isolates are specifically Pseudomonas aureginosa.
30
 
In 1999, Tentolouris.N et al, said that diabetic wound infections caused 
by Methicillin Resistant Staphylococcus aureus was 30%.
31
 
In 2000, Campbell.LV et al observed that about 60% of diabetic ulcers 
were due to neuropathy, about 20% were due to is chaemia and 20% were 
mixed, Which mean that about 40% of diabetic ulcers have an ischaemic 
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components which will affect the plan of care. On examination neuropathic 
foot generally appear as dry, painless, warm, insensate. Ischaemic foot usually 
cold, atrophic skin, dystrophic nails, absent pulses. Sporadic clauducation may 
be present. The study stressed to monitor ulcer status and identify change over 
time, several important characteristics including size, location and presence or 
absence of infections to be assessed and documented.
32
 
In 2000, Fryberg.R.G et al, published that charcotarthropathy is a 
structural abnormality in which joint instability due to muscle and ligament 
atrophy. Walking a weakened, insensate joint causes structural damage and 
results in sprains and stress, fractures to the foot. The acute stage presents as 
inflammatory response with bone resorption and then leads to bone destruction 
with destruction arch of foot presence as rocket bottom sole and the altered 
pressure distribution may increase the risk of ulceration.
33
 
In 2000, Sinacore et al observed that many secondary aging factors 
also implicated in delay wound healing. In addition, patient education,  healing 
potential,  physical environment, wound management  and quality of life also 
are  the factors implicated in delayed wound healing. 
34
 
In 2000, Sibbalal et al had detected that intervention to promote wound 
healing includes control of infection, tissue debridement, avoid further trauma, 
moist wound environment with proper dressing, oxygenation, perfusion, 
provision of education, foot wear examination.  In tissue debridement, the 
Review of Literature  
 
 
19 
 
purpose is to remove the dead or devitalized tissue. In  the management of 
diabetic foot ulcers, common techniques were used such as mechanical 
debridement which is irrigation with saline solution, wet to dry dressing. 
Autolytic debridement (hydro colloids, hydrogels) and surgical debridement, 
which was the method of choice for wounds with large amount of devitalized 
tissues or infection, however surgical debridement must be performed only on 
tissue with adequate blood supply or blood circulation.
35
 
In 2000, Lipsky.B.A et al, said that several studies have confirmed that, 
receiving prior antibiotic treatment for chronic infections or lesions were 
usually polymicrobial.
36
 
In 2001, Calhorn et al, observed that in controlling infection, 
intervention depends upon the nature of the infection (acute, chronic and 
systemic). However general interventions for all wounds  promote healing. In 
addition to debridement, it is necessary to control bacterial balance, support 
host defense and support medical and pharmacological intervention.
37
 
In 2002, Calhoun et al, obsevered that in diabetic wound dressing, no 
one dressing was appropriate for all diabetic wounds or the various stages of 
healing. Selection of dressing was  made on the basis of healing potential and 
clinical assessment of ongoing wound status. Wound dressing categories 
include film or transparent, hydrating (hydrocolloids and hydrogels), moisture 
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retentive (adherent or nonadherent), absorbant (hydrofibres, foam, hypertonic 
saline, algineter) and antimicrobial (cadixomer iodine, silver agents).
38
 
In 2002, Abbott.C.A et al proved that 55% of foot ulcers are due to 
pressure from foot wear which can cause trauma to the foot, with reduced 
circulation and loss of sensation. Assessment should include checking for 
callus foot wear and structural abnormality.
39
 
In 2003, Merza.Z et al, had described that in diabetic foot some of the 
risk factors such as biomechanical factors, smoking, level of glycemia were 
strongly associated with environmental factors. In certain societies factors 
such as average monthly house hold income, racial distribution, education 
level may contribute to diabetic foot prevalence.
40
 
In 2003, Jeffcoate et al,  discussed about the optimation of wound 
environment which involves a number of component. This include assessing 
the wound bed for bacterial balance, exudates and need for debridement. 
Selection of dressing that can control or manage the wound environment, 
maintaining a moist wound bed as required, while keeping the surrounding 
wound skin dry, controlling exudates without dessicating the ulcer bed, 
eliminate dead space by loosely filling the cavity, ensure that there is adequate 
pressure relief in the affected area.
41
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In  2004Anadhi C et al said that in diabetic foot patient , risk of leg 
amputation was 15-46 times higher than non diabetic patient . Peripheral 
neuropathy and poor circulation were the major factors  for developing foot 
ulcer . In diabetic foot infections were usually polymicrobial ,where the milder 
infections are monomicrobial .
42
 
In 2004, Schultz G.S etal suggested to evaluate patient wound status 
and compatibility with treatment goals. The wound edge should be examined 
to determine the presence of cell migration and wound closure. If wound 
healing was not occuring, status of those factors could be corrected.
43
 
In 2004, Farish.P.L et al, said that incase of ischaemic diabetic foot, 
Bypass surgery is a common method of treatment and reported long term 
result. Ten years limb salvage rate with surgical bypass of lower limb was 
upto 90%. In case of multiple occlusion, revascularisation at each point to 
restore arterial blood flow and increase the chance for limbs salvage. 
Transluminal angioplasty of the iliac artery in conjunction with surgical 
bypass in the distal extremity may be implemented and efficiency has been 
demonstrated in diabetic patients.
44
 
             In 2004, RNAO (Registered nurses association Ontario) conveyed that 
nurses have a major role to identify the emerging problem, to promote 
maintainance of healthy feet, advice the client of their risk factors. In literature 
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it have been identified that five primary risk factors that can be quickly 
assessed and screened by nurses.  
These factors are: 
• Circulation. 
• Sensation. 
• Past history of foot ulcer. 
• Structural and biochemical abnormalities. 
• Knowledge and selfcarebehaviour. 
The presence of one or more of this risk factors is favour for developing 
foot ulcer and amputation of lower limb. Nurses contribute a key role by 
identifying such risk factors, informing and providing referrals for clients at 
risk to prevention strategy. 
In 2004, Lipsky.B.A et al, reported that in India 40 million people are 
suffering with diabetes mellitus and of equivalent magnitude in other 
developing countries. In that upto 20% of patients were struggling with 
diabetic foot complications and hence are the most commonly faced surgical 
problem. In treatment was not appropriate, it may lead to amputation or 
disarticulation of varying levels, atleast once in  such patients life time. Most 
of the diabetic foot infections are initially treated empirically based on the 
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clinical knowledge of the treating doctor and the prevalence of the microbial 
pattern in the hospital and locality. It would be prudent if the treatment is 
directed based on the hierarchy of the organisms most commonly isolated and 
the most common antibiotic sensitivity pattern of these organisms, at the onset 
and thus help in a better outcome. Several studies have been conducted  world 
wide with respect to the bacteriology and antibiotic sensitivity pattern. A 
number of studies have found that Staphylococcus aureus and other gram 
positive aerobes were the most common causative pathogens, usually isolated 
in more than 60% of cases.
45
 
In 2005, Koneman.W.K et al have shown the selection of antibiotic 
agent for treating diabetic foot infection require the knowledge of the potential 
microbial pathogen and the resistance to the commonly used antibiotics. To 
assess the right antibiotic to manage the diabetic foot ulcer infections, the 
result of misuse and abuse of specific antibiotic studies were needed.
46
 
In 2005 Lipsky.BA et al ,conducted  a multicentre study (‘SIDESTEP’)  
showed Ertapenem was ineffective against pseudomonas, compared with 
Piperacillin / Tazobactam. Although in some wound cultures involved by 
Pseudomonas aeruginosa, revealed similar  outcomes. The authors from this 
study and several other studies from western countries said that Pseudomonas 
aeruginosa was the commensal organism rather than a pathogen,  since could 
not require any specific antimicrobial coverage to eradicate Pseudomonas 
Review of Literature  
 
 
24 
 
aeruginosa, need wound care measures, such as avoiding moisture in the 
periwound area, frequent changing of wound dressing and avoiding 
hydrotherapy based wound care.
47 
In 2005, Singh.N et al said that in India diabetes associated problems 
are the second most common cause of lower extremity amputation.
48
 
 In 2005, Bakker.K et al, said that globally, every 30 seconds one lower 
limb is lost due to diabetic foot ulcers.
49
 
 In 2006, Kulkarni.J et al reported that 50% of amputed patients will  
die within five years of amputation, according to USA data mortality in the 
group of diabetic foot complications was comparable to the mortality in some 
types of cancer.
50
 
In 2006, Tsae.S.M et al, said that Staphylococcus aureus infection in 
the diabetic foot accentruted the inflammatory process, endothelial injury and 
blood coagulation, ultimately leading to quicker death.
51 
 In 2007 Citron D .M  et al observed that anaerobes was almost always 
present in mixed culture . F.magna was predominant organism this was in 
contrast to other study ,which failed to isolate anaerobic gram positive cocci 
due to not using selective media for anaerobic gram positive cocci ,suboptimal 
collecton and transport methods .Most frequently used selective anaerobic 
medium was brucella agar with laked blood ,kanamycin , and 
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vancomycinagar, growsB. Fragilis group and Prevotella species ,but not gram 
positive anaerobes .
52
 
 In 2007,Stansbury.L.G et al described that in diabetic patients foot 
amputation ratio was higher than soldiers taking active part in military, which 
incorporate 2.3% of all battle injuries and 7.4% of major limb injuries.
53
 
In 2008, Frykberg.R et al found that in diabetic and neuropathy patient 
may develop charcotosteoarthropathy  which was characterised by progressive 
destruction of bones and joints of the diabetic foot accompanying with 
osteopenia. Incidence of this complication, range between 0.1% to 30%. In 
about  25% of charcotosteoarthropathy may be missed or diagnoses may be 
delayed due to lack of specific markers of charcotosteoarthropathy, which may 
lead to significant deformity, ulceration and amputation of foot.
54
 
              In 2008 Flynn.N et al, said that Staphylococcus aureus is most 
important pathogen among the staphylococci and found in the environment 
and anterior nares of 20 to 40% of adults. Other sites of colonisation are axilla, 
vagina, skin fold and the perineum. Staphycoccusaureus has a variety of 
virulence factors and the ability to develop and expand resistance to broad 
spectrum antibiotics. Patients with diabetic foot infection is the major cause of 
morbidity. They occur in 15% of diabetic patients and 20% of all hospitalized 
diabetic patients.
55 
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In 2009 Paul S et al said that foot ulceration and infections are the most 
frequent serious complication of diabetes mellitus . The annual incidence of 
leg and foot ulcer was 2.6,5.33, times more common than diabetic coronary 
disease, stroke, renal failure respectively . About 15% of diabetic patient  
develop foot ulcer in their life time . Studies past 25 years on bacteriology of 
diabetic foot  infections , but the results are varied and contradictory .
56 
In 2009, Orji.F.A et al, have shown that incidence rate was high in 
males. Polymicrobial organisms (56%) were higher than monomicrobials 
(53%). Prevalence rate of the bacterial isolates were Clostridium species 51%, 
Staphylococcus aureus were 60%, E.coli 20% and Klebsiella aerogenes 12%. 
Antibiotic sensitivity pattern of Clotridium species showed sensitive to 
Fluoroquinolones and high resistance to beta lactams. E.coli and 
Klebsiellaaerogenes  showed resistant to beta lactams and aminoglycosides. 
All gram negative organisms showed significant sensitivity to 
fluroquinolones.
57
 
In 2010 Zubair M observed that prevalence of diabetic foot ulcer in 
male was to be 56.6% and female was 30% and ratio of 3.5:1 . bacteriological 
evaluation of diabetic foot ulcer infections showed that  prevalence  of gram 
negative organisms were found to be more than gram positive  organisms .The 
prevalence of multi drug resistant organisms was high in diabetic foot ulcer 
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patients in india due to misuse of antibiotics , this  leads to longer duration of 
hospital stay and their treatment could be more coastly .
58
 
In 2010 Shakil.S said that diabetes patients have 10 times higher  risk 
of being hospitalised than non diabetes for soft tissue and bone infections . By 
the year 2025 in India diabetic populations is expected to increase to 57 
million.
59
 
In 2011 Chopdekar K.A et al did a study on bacteriological profile of 
diabetic foot infection ,out of 113 samples ,a majority  of samples  that is 96 
(85%) showed polymicrobial growth of which,  29 was mixed growth of only 
aerobes 67 was mixed growth of aerobes and anaerobes. Out of 290 isolates 
,223 were aerobes 67 were anaerobes . Among the aerobes gram negative 
bacilli were 133 , gram positive cocci were 90 ,majority were Staphylococcus 
aureus (50) , followed by Pseudomonas  aeruginosa (47), Acinetobactor 
species(2)among the anaerobes ,46 were gram positive cocci, 21 were bacilli 
in that 16 were gram negative and 5 were gram positive. The majority of 
anaerobes were Peptostreptococcus   species 38(57%) , followed by anaerobic 
streptococci 8(12%).
60
 
In 2011 Pappu A.K et al did a study on microbiological profile of 
diabetic foot ulcer out of 104 samples ,average of 1.08 species per diabetic 
ulcer patient . In that more than one organism was isolated in only 7.7%. Gram 
negative aerobes was isolated in 76%, gram positive cocci in 24%. Among the 
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gram negative aerobes, Pseudomonas was 23% isolated,followed by 
Klebsiella(17%) , Proteus mirabilis(15%),E.coli (12%), Acinetobactor(6%), 
Proteus vulgaris (2%) and Streptococci (4%) . Second commonest was 
Staphylococcus aureus(21%). No anaerobes were isolated .22% of amputees 
each  were infected with Psedomonasaeruginosa and Proteus mirabilis ,18% 
Klebsiella, 14% Staphylococcus aureus in that 6% were methicillin resistant 
and Acinetobactor 4% infections in amputees .
61
 
In 2012 Banashankari G.S observed that choice of specimen for 
culture and sensitivity was tissue and more specific and sensitive than swab 
because it yielded pathogenic organism by eliminating contaminants but the 
same time isolation with swab was reliable ,but there is a possibility of 
isolating only contaminant, it has to be done with  at most care. All ulcers  
were thoroughly  washed with sterile saline  to avoid the colonizer rather than 
pathogenic and specimens were collected by scraping from base of ulcer , 
wound curettage or aspiration rather than wound swab . Majority of isolation 
was single organisms it was 64% and rest were polymicrobial and about three 
or more organisms were 5% .Aerobic facultative organisms were isolated in 
98% , anaerobic was 2% . In that  66% gram negative isolates were isolated 
with predominant organisms being Proteus which was 18% , E.coli were 16% 
and Pseudomonas 13% . Among the gram positive organisms 19% were  
Staphylococcusaureus followed by Enterococcus were 9% , coagulase 
negative Staphylococcus were 5% . Gram negative to gram positive ratio was 
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1.5:1 . Minimal contaminants  and minimal isolation of Staphylococcus 
epidermidis due to tissue technique method (56%), less use of swab . 18.4% 
were gram positive organisms,34% were gram negative organisms,remaining 
had grown both (gram positive and gram negative organisms) .
62
 
In  2012 Esmat M.M et al observed that diabetes patients have risk of 
developing diabetic foot ulcer in their life time as high as 25% . 15 to 45 times 
higher risk of limp amputation in diabetic ulcers than ulcers due to other  
causes .
2
 
In 2012 Manisha J et al observed that prevalence of diabetes mellitus 
depends upon many factors, that is age, sex, socio-economic status, diet, 
heredity, physicalactivity, life style and environmental factors.  Incidence 
ranges in the annual population from 1.0% to 4.1%, prevalence ranges from 
4% to 10% and the life time incidence as high as 25%.Males to females ratio 
was2.1:1, the mean age of patients was 50.25 + 12.5.
63
 
 In 2012, Tiwar.S et al, found that diabetic ulcer with 
polymicribialinfection had comparatively higher total leucocyte count 
(16,928+ 9,642 versus 14,593+6,687) and haemoglobin level significantly 
lower (7.9+2.4 versus 9.2+ 2.2) than monomicrobial infections. HbA1C level 
in both groups were similar (9.9% versus 9.5%).Patient infected with gram 
negative bacteria were also had significantly lower level of Hb (8.5 + 1.9 
versus 11.1+ 2.2), total leucocyte count was higher (16,280+ 6806 versus 
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9771+ 3243). Neutrophils level was higher (77 versus 67), than infected with 
gram positive bacteria.While infected with both gram positive and gram 
negative bacteria had significantly lower level of Hb (7.6 + 3.2 versus 11.1 + 
2.2), than infected only with gram positive microorganism. But this was 
insignificant when patient infected with only gram negative micro organism. 
In case of culture negative suspicion of infection was high can use molecular 
techniques for diagnosis of bacterial infection. To differentiate infected from 
noninfected foot ulcers, inflammatory markers  were used. However positive 
culture and sensitivity result have a priority over the molecular study for the 
selection of antibiotics.
64
 
In 2012, Shim.V.R et al, detected that males were more prone for 
diabetic foot ulcers than females. This may be due to differences in 
biomechanics between male and female, specifically high foot pressure 
decrease joint mobility. Male have nearly twice the odd of having insensate 
neuropathy as women with diabetes.
65
 
In 2012 McInnes.A.D et al suggested that diabetic foot protection team 
working across primary and secondary care could reduce length of hospital 
stay for diabetic foot ulcer, also reducing major amputation ratio. Median 
length of hospital stay over the period of three years for diabetic foot ulcer , 
decreased from 47 days to 19 days.66 
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In 2012 Blumberg.S.N et al suggested that an innovate and promising 
treatment for diabetic foot ulcer is stem cell theraphy.
67
 
 In 2012, Forbes.J et al, said that, in the treatment of wound amniotic 
membrane has been used which is rich in collagen and various growth factors 
and it will support the healing process to improve the wound closure and it 
will reduce the scar formation. In early they have been used natural amniotic 
membrane which obtained from labour and delivery. Recently techniques have 
been developed to dehydrate the material while preserving many of these 
wound healing attributes to produce temperature stable allograft.
68
 
 In 2013 Konar.J et al reviewed that wound healing was a stepwise 
repair of lost extra cellular matrix that forms largest component of the dermal 
skin layer. Accurate and controlled rebuilding is necessary to avoid over or 
under healing that may lead to various abnormality. Sometimes wound healing 
was disturbed by certain disorder and physiological insult. One such disorder 
was diabetes mellitus, disturbs the normal steps of wound healing process. 
Many histopathological studies show in diabetic wound inflammatory phase 
will be prolonged, this leads to delay formation of mature granulation tissue 
and parallel reduction in wound tensile strength. 67cases out of 150 identified 
bacteriology etiology (38%), single organism was isolated in 58 (87%) among 
which Pseudomonas aeruginosa was the commonest (21 cases), followed by 
Escherichia coli (16cases), and Staphylococcus aureus (15 cases ), Proteus 
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vulgaris, Enterococcus, Klebsiella pneumoniae were each 2 cases. 
Polimicrobial was isolated in 9 cases ,in that Staphylococcus aureus along 
with Klebsiella oxytoca was isolated in 4cases, rest of 5 cases isolated 
Pseudomonas aeruginosa with Escherichia coli .Among 50 gram negative 
bacteria, 23(46%) produced ESBL, 17(33.33%), were Amp C beta lactamase 
producers and carbapenamase producers were4(8%); 33 gram negative isolates 
were resistant to fluoroquinolones  (66%). Extended spectrum beta lactamase 
producers were Escherichia coli  followed by Pseudomonas aeruginosa.  
Carbapenamase producers was exclusively Pseudomonas aeruginosa .Amp C 
beta lactamase producers was Pseudomonas aeruginosa followed by Klebsiella 
pneumonia andKlebsiellaoxytoca. Out of 19 isolates of Staphylococcus 
aureus, 7 were methicillin resistant (36.84%). All Staphylococcus aureus were 
sensitive to both linezolid and vancomycin. One Enterococcus faecium was 
vancomycin resistant and MIC value was > 64mic.gram/ ml and was sensitive 
to teicoplanin, Dalfopristin/Quinupristin and Linezolid. Isolated Enterococcus 
faecium were resistant to Penicillin, Gentamycin, Tetracycline, 
Fluoroquinolone leaving behind very restricted therapeutic options .
69
 
 In 2013 Shanmugam.P said that poor micro vascular circulation in 
diabetic ulcer patient, limit the phagocytes  and favour the development of 
infection .Improper foot wear and local injuries further compromise blood 
circulation in the lower extremities .diabetic foot infections are initially treated 
empirically , which against known causative organisms improve the outcome. 
Review of Literature  
 
 
33 
 
Many studies in the past 25 years reported on bacteriology of diabetic foot but 
the results were varied and often contradictory. These could be due to 
differences in the causative organisms occurred over time, geographical 
variation, type and severity of infections. Most of the time diabetic foot 
infections were polymicrobial , proper management of the infections requires 
an appropriate antibiotic selection based on cultures and antimicrobial 
susceptibility testing results. In recent years increase in the incidence and 
prevalence of extended spectrum beta lactamase and carbapenemase producers 
may be due to paucity of data on extended spectrum beta lactamase and 
carbapenemaseproducers .
70
 
 In 2013, Rani.KL etal observed that out of 150 cases of diabetic foot 
107 were males and 43 females, which mean that diabetic foot infections were 
common in men than women. This could be because diabetes is more common 
in men, and are prone for trauma because of their outdoor work. In this study 
they found that diabetic foot infection were common in 40 to 60 year age 
group. Out of 150 cases, 98.66% was non insulin dependent diabetes mellitus 
(NIDDM) type. In this study 53.6% of the cases was suffering from diabetes 
mellitus for more than 6 years. Enterococcus species was isolated only from 4 
cases (1.85%) but in most of other studies they isolated in a range of 4 to 30%. 
Gram negative bacilli was isolated more commonly in this study which was 
188 (87.03%).  Among gram negative organism Escherichia coli were the 
most common 25.46% of the total isolates, followed by Proteus mirabilis 
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(23.14%) Pseudomonas aeruginosa (13.42%) Klebsiellapneumoniae (12.03%) 
and the other gram negative bacilli were Proteus vulgaris (6%) 
Citrobacterfreundii (1.85%), Enterobacter species (3.7%), 
Morganellamorganii (1.38%). 
 In the management of diabetic foot infections, extended spectrum 
cephalosporins group of drugs shows good results. The patients with 
necrotising infections are severely ill, require broader antibiotic coverage. 
Sensitivity pattern of Staphycoccusaureus were Vancomycin 100%, 
Cefotaxime (65.2%), Ceftazidime (56%),  Clindamycin (34.78%), Gentamicin 
(34%) and Ampicillin (34%), Ofloxin (34%) and Amikacin (30.4%). This 
study showed higher rate of resistance. This due to patients received treatment 
early which could have eliminated sensitive organisms and remain only 
resistant organism. Sensitivity pattern of Enterococcus species were 
Vancomycin (100%), Amikacin (50%), Gentamicin (25%), Netilmicin (25%), 
Ofloxacin (25%), Cefotaxime (25%), Ceftazidime (25%), Ceftriaxone (25%). 
Gram negative bacilli  is more sensitive to Imepenem,  Piperacillin/ 
Tazobactam, Piperacillin, Amikacin, Cefotaxime, Ceftazidime, Ceftriaxone 
and Gentamycin, Ofloxacin. 
In this study Escherichia coli was the most common isolate (25.46%), 
which was sensitive to Imepenem (96%), Piperacillin/ Tazobactam (90%), 
Cefotaxime (76.6%), Piperacillin (72%). Amikacin (65.45%), Ceftriaxone 
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(54.5%), Ceftazidime (49%), Gentamicin (30.9%) and Ofloxacin (30.9%). 
Proteus mirabilis sensitive to Imepenem 98%, Piperacillin/ Tazobactum 90%, 
Cefotaxime 60%, Ceftriaxone 58%, 90% sensitivity to Amikacin. Proteus 
vulgaris was sensitive to Amikacin 79%, Cefotaxime 38.46% and other 
routinely used antibiotics showing maximum resistant. 
Enterobacter species sensitivity pattern was Ofloxacin (87.5%), 
Cefotaxime (75%), Amikacin (75%), Ceftazidime (62.5%), Gentamicin 
(50%), Ceftriaxone (50%). Citrobacterfreundii sensitive to Cefotaxime was 
50% and Ceftriaxone 50%.  Morganellamorganii was sensitive to Cefotaxime 
66%, other antibiotics were 33%. Pseudomonas species was   sensitive to 
Imepenem 93%, Piperacillin/ Tazobactam 83%, Piperacillin 83%, Amikacin 
was 55%, other routinely used antibiotic were less sensitive.  
 Patient education was the most important aspect, once patient was 
diagnosed as diabetes, it is  doctors responsibility to advice the foot care in 
diabetic and make them understand the complications of diabetic foot 
infection.
71
 
In 2013, Turhan.V et al reported that in diabetes foot infections 
Staphylococcus aureus was long been recognized as the predominant micro 
organism but in this study it was second frequently isolated organisms. In 
1990 community acquired MRSA emerged as the important isolates in 
diabetic foot infections, incorporate between 12 to 40% of all Staphylococcus  
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species. 44.2% methicillin resistance strain isolated in this study. They found 
that fusidic acid was effective against all Staphylococcus species, including 
MRSA and in mild to moderate diabetic foot infection, Fusidic acid may be 
considered as an important therapeutic alternative.
72
 
In 2013, Salihi.S.A et al, did a study on 25 patients with diabetic ulcer. 
In that 17 were non insulin dependent diabetes mellitus, 8 were insulin 
dependent diabetes mellitus and they belong to age group between 40 to 49 
years. This may due to repetitive mechanical force of weight during working. 
All the 25 samples isolated showed pure form of isolates. Among that 14 
(56%) were E.coli, 7 (28%) were Proteus mirabilis and 4 (16%) were 
Staphylococcus aureus.  Antibiotiuc pattern of E.coli was more sensitive to 
Rifampicin, Ciprofloxacin and Nitrofurantoin. From this study they found that 
Gentamicin had highest antibacterial activity to E.coli 85.7%, Proteus 
mirabilis 42.8%, Staphylococcus aureus 75%, while antibiotic resistance of 
Nalidixic acid to E.coli was 100%, Proteus mirabilis 71.4%. Multidurg 
resistant may be due to chronic course of admission and chronicity of the 
wound.
73
 
In 2013, Hameedhefni.A.A et al, identified that the diabetic wound 
infections begins superficially, but delay in the treatment and impaired body 
defence mechanism infection can spread through deeper tissues which leads to 
complications such as gangrene and amputation.
74
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 In 2013, Jaya.M  et al evaluate that maximum number of patients 
between the age group of 60 to 65 years. Totally 75 organisms isolated from 
50 patients. He isolated monomicrobial and polymicrobial  25% equally. 
Among the isolates gram negative bacilli was isolated more than gram positive 
cocci. In gram negative bacilli, Pseudomonas species was higher (16%) 
followed by E.coli (14.6%) and the other organisms were Methicillin sensitive 
Staphylococcus aureus (13.3%), Streptococcus pyogens (10.6%), Klebseilla 
species (8%), Acinetobacter species 8%), Methicillin resistant Staphylococcus 
aureus (8%), Proteus mirabilis (6.6%), Citrobacter species (5.3%), 
Enterococcus species (5.3%), coagulase negative Staphylococcus (2.6%), 
Enterobacter species (1.3%). 
 Among the gram negative bacilli 37.5% of the isolates were extended 
spectrum beta lactamase (ESBL)  producers, 31% of isolates were 
Carbapenamase  producers. Diabetic foot ulcers were ischaemic 74.1% 
followed by neuropathic type. Most common locations of diabetic ulcer was 
toes (big toe followed by second toe) plantar region of the foot and dorsum of 
foot, which was  >70%.
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 In 2013, Madanchi.N et al, did a descriptrive study on 873 diabetic 
ulcer patients. He found that mean duration of diabetic foot ulcer prior to 
admission was 79.8 days. Mean haemoglobin A1C (HbA1C) level was 9.51% 
and HbA1C less than 7% was 14.4%. Previous history of lower limb 
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amputation was 16.4% of patient. In that 4% of patients had major amputation 
(above ankle), and 12.5% had minor amputation. Majority of patients had 
ischaemic type of diabetic foot ulcer  was 74%, Neuropathic diabetic foot 
ulcer was 17.4% and neuroischaemic  (both type) was 8.5%. Diabetic foot 
ulcer in the right lower limb is 53.4%, in the left lower limb 38.8% and both 
lower limbs are 7.8%. Most common location of diabetic foot ulcer was in big 
toe. Followed  by  second toe. Diabetic foot ulcer at the site of previous 
surgeries like debridement, amputation or venous graft removal for coronary 
artery bypass graft (CABG).  
 Out of 873 patients 28.2% of patients underwent lower limb 
amputation, in that 38.3% was major amputation, 61.7% was minor 
amputation. Mean duration of hospital stay was 16.7+/- 11.3 days, and 
mortality rate was 5.2%. Most of the patients developed diabetic foot ulcer in 
the mean age of 59.3 years. Other studies also found that diabetic  foot ulcer to 
be 55- 60 years. In the study population male patients was dominant, which 
was 58.1%, Other studies also reported the same, that in the average of 50%- 
63.3% in their study population.  
Most of the patients 85.6% had uncontrolled diabetes mellitus, their 
HbA1C level was more than 7%. It is suggesting that diabetic foot ulcers are 
mostly developed in poorly controlled diabetes mellitus. Due to diabetes 
mellitus comorbidities 69.6% of cases had preceding episodes of 
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hospitalization. More than 50% of the patients had renal and cardiovascular, 
more than 40% had ophthalmic comorbidities.  
Diabetic foot ulcer was more common in patients with past history of 
amputation and foot ulceration which was 57 times higher than patients 
without this history. 22.4% of patients had previous of hospitalization because 
of diabetic ulcer. Previous hospitalization due to other comorbidity of diabetes 
mellitus including renal, cardiovascular, cerebrovascular, ophthalmic 
complication was 47.2%. Relationship between diabetic foot ulcer and 
comorbidity was controversial but many reports found that comorbidity is an 
independent risk factor for development of diabetic foot ulcer and amputation. 
He found that 74.1% of diabetic foot ulcer was ischaemic type followed by 
neuropathic type. To compare right lower limb to left lower limb, diabetic foot 
ulcer by ratio, It was 1.37:1, it is because most patients are right dominant, 
using more on right which may expose to trauma. Most common locations of 
diabetic foot ulcer was toes (big toe followed by second toe), plantar region 
and dorsum of foot, which was more than 70% of the patients in the study. 
Comparing with proximal part, distal part of limb was more affected. This is 
mostly because of is chaemia, diabetic neuropathy and trauma. Diabetic foot 
ulcer at the site of previous surgery was identified in 26 patients, which 
suggesting to avoid unwanted surgical procedures in left of diabetes mellitus 
patients. Average stay of hospitalization was 16.7 days and 28.2% of patients 
needed amputation, major to minor amputation ratio was 1.61:1, amputation 
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rate will vary from different report in different countries. This study suggested 
that multi disciplinary approach (by a team of Orthopaedic surgeon, 
Endocrinologist, Vascular surgeon, Infectionist, Internist, Interventional 
cardiologist, General practioners, Nurse, Physiotherapist) decreases the 
amputation rate, because multidisciplinary approach is for early detection, 
prevention, personal education and multiple therapies (dressing, drainage, 
frequent debridement, washing along with antimicrobial therapy and daily 
assessment of wound healing).
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In 2013, Zycover.S et al, did a randomised, double blind, placebo 
control study and he indicated that in the treatment of diabetic foot ulcers, 
soluble beta glucans were effective. Soluble beta glucans are available with 
the brand name woulganbiogel.
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In 2014 Kaur. N et al did a study on clinical susceptibility profile of 
diabetic foot and observed that , out of 106 samples were cultured ,in that 98 
was culture positive ,136 organisms was isolated averaging of 1.38 organisms 
per positive culture. No growth was obtained in 8 patients (7.6%) . Growth of 
one organisms showed in 70 (71.4%) ,growth of 2 organisms was showed in 
18 (18.36%) ,and three or four organisms were isolated in 10 patients (10.2%) 
. Most commonly isolated organisms were gram negative , which was 67.6%, 
gram positive organisms were 28.6% ,while yeast were 3.67% . Among the 
gram negative bacteria , most frequent were Proteus species (27) , followed by 
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E.coli (25) . Among the gram positive bacteria S.aureus (25) . Most effective 
antimicrobial agent against gram negative  were Meropenem, Polymyxin B, 
Imipenem, and Piperacillin/Tazobactam. While Linezolid ,Vancomycin , 
Amikacin were most effective against gram positive  organisms.
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In 2014, Kavitha.Y et al, reported that diabetic population in India 
about 50.8 million, by 2013 which is expected to increase 87 million. Among 
the diabetes patients, risk of developing a foot ulcer was 15%. Based on recent 
studies incidence ranges from 1.0%  to 4.1% and the prevalence range from 
4% to 10%, suggesting that the life time incidence as high as 25%. In diabetic 
ulcer patient therapy against known causative organisms may improve the 
outcome. More than half of the patients who underwent lower limb 
amputation, will have within five years contralateral amputation. Half of those 
who underwent amputation will die within three years.  
Staphyllococcusaureus, E.coli, Klebseilla species, Proteus species, 
Pseudomonas species and Enterococcus species are the most frequent isolates 
from diabetic foot ulcers. The diabetic foot infections were usually 
polymicrobial due to aerobic, anerobic and Candida species. The severe 
infections were usually polymicrobial isolates, whereas milder infections are 
usually monomicrobial. The organisms found in diabetic ulcer infections differ 
not only patient to patient or hospital to hospital but also from one part of the 
country to another part of the country. 
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 Diabetic foot ulcer was one the most common complications requiring 
hospitalization. Male patients are predominant in the study population and 
maximum number of patients belongs to Wagners  grade 3. Diabetic foot 
ulcers were usually polymicrobial infection, but in this study monomicrobial 
organisms were predominant. Gram negative bacilli were isolated more than 
gram positive cocci. 
 Among the organisms Staphylococcus aureus was predominant (21) of 
about 32.3% followed by Klebseillapneumoniae(10) 15.38%, Pseudomonas 
aeruginosa (8) 12.31%  but in other studies gram negative organisms were 
predominent. This could be due to over time, geographical variations and 
types and severity of infections. Most of the gram positive cocci was highly 
resistant to Erythromycin, Cephalosporins and Gentamicin. But they were 
sensitive to Amikacin and Clindamycin. All the gram positive cocci were 
sensitive to Vancomycin. Most of the gram negative bacilli were found to be 
highly resistant to Cephalosporins, Ciprofloxacin, Cotrimaxazole and 
Gentamicin. But they show good sensitivity  to Amikacin, Piperacillin/ 
Tazobactam, Imepenem. 
Even if the microorganisms were sensitive to some particular antibiotic, 
drug is unlikely to reach the therapeutic concentration at the site of infection 
due to virulence factors such as hemolysins, collagenase, proteases and short 
chain fatty acids that cause impede wound healing process, inflammation  and 
Review of Literature  
 
 
43 
 
chronicity of the infection of wound. In diabetic foot microbial infections were 
not consistent so that repeated evaluation of microorganisms and their 
antibiotic sensitivity were necessary for the selection of appropriate 
antibiotics.
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In 2014, Sudaresh.N.J et al reported that compare to female, males are 
predominantly prone to post  surgical infections. Most of the patients age 
group were 51 to 60 (28), followed by 61 to 70 (26) and 41 to 50 (23). Age 
factors was playing an important role in developing infections and contribute 
with other factors such as economical status and polypharmacy. Average 
bacteria per lesion was found to be 1.22. Gram negative organisms were 
dominated than gram positive and polymicrobial nature were observed. The 
most frequently isolated organisms were Staphylococcus aureus (39.34%) 
followed by E.coli (23.77%), Enterococcus (4.91%), Pseudomonas aeruginosa 
(9.83%), Klebseillapneumoniae (7.37%). Proteus species (6.5%), 
Acinetobacter species (3.27%), Citrobacter species (1.63%). 
Sensitivity pattern among gram positive bacteria were 
Cefoperazone/Sulbactam (100%), Piperacillin/Tazabactam (100%), 
Clindamycin (100%), Ofloxacin (91.67%), Rifampacin (93.65%). Resistant 
pattern among gram negative organisams was Penicillin (8.33%), 
Cotrimaxazole (0%), Kanamycin (0%) and Erythromycin (6.0%).80 
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In 2014, Kamtikar.R et al did a study on microbiological profile of 
diabetic foot  out of 77 patients, they isolated 104 organism, among that mono 
microorganism is dominative which was isolated from 68 patients and  
polymicrobial was isolated in rest of the patients. The study compared with 
other studies in which they reported that polymicrobials was 64.4% to 83.8%. 
This difference may be due to local pattern of antibiotic usage, absence of 
severe and deep wounds, demographic characters and low virulence of 
microorganisms isolated in this study.  In this study, out of 104 microorganism  
66 are gram negative organism and is dominative. Among this gram negative 
organism, Pseudomonas aeruginosa was the most common organism isolated 
which is about 39 (37.5%). Pseudomonas aeruginosashowed  highest 
resistance to commonly used antibiotics and the highest resistance was seen 
with Ciprofloxacin , Ofloxacin and levofloxacin with Aztreonam and 
Imipenem. Other studies also have reported similar findings.
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In 2014, Suganthi.P et al, published a study on bacteriological profile 
of diabetic foot. Out of 60 patient, 28 (56%)  had monomicrobial which is 
higher than polymicrobial 22 (44%). From  60 samples, 10 samples did not 
yield any growth. Among the 50 positive culture gram positive organism were 
isolated more which was about 51 (63%), gram negative were 30 (37%). 
Among gram positive organisms Staphylococcus aureus was predominant 
which was 25% followed by Staphylococcus saprophyticus 15%. Among the 
gram negative predominant isolate was Pseudomonas aeruginosa (25%) 
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followed by E.coli 4%. In the antibiotic sensitivity pattern Oxacillin, 
Vancomycin werethe effective drugs against gram positive organism. 
Meropenem, Piperacillin, Piperacillin/Tazobactam, Ticarcillin/ Clauvulanic 
acid, Amikacin were the effective drugs against gram negative organisms. 
Among the combination antibiotic Piperacillin/ Tazobactam found to be an 
effective drug of  choice.
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In 2014, Sridhar.K et al, did a study on clinic- bacteriological profile 
of diabetic foot infections, Out of 66 pseudomonas isolates screened for AMP 
C beta lactamase, in that 18 were positive, which was 27.2%. Extended 
spectrum Beta lactamase screened in 59 isolates of Klebsiella species and 31 
E.coli, in that 44% in Klebsiella were ESBL producers. And 32.2% E.coli 
were ESBL producers.
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In  2015 Chavan .S.K et al said that diabetes mellitus is a chronic 
disorder  and major public health  problem in india .Foot ulceration was a 
most common complication in diabetes mellitus patients ,approximately 15% 
of during their life time .Amputation of limb has a major impact  not only 
changing the body image , increasing the dependency and cost of treatment . 
Choosing the empirical antibiotic on diabetic foot ,requires the knowledge 
about etiologic agents ,improper treatment may develop multi drug resistant . 
Extended spectrum beta lactamase producing multi drug resistant were 
reported frequently and 15-30 % diabetic wounds were infected with 
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methicillin resistant Staphylococcus aureus .  Multi drug resistant organism 
causing infections may increase the hospital stay and cost of management. 
Maximum diabetic foot patients were above the age  50 years , age 
increase incidence of diabetic foot also increase .Majority of diabetic foot 
patients were diabetes mellitus type 2, comparing with female ,male patients 
were more that is 76.9% . Majority of ulcers were grade 2 and 3 (53.8%) . 
most common cause of diabetic foot were noted as neuropathy ,which was 
56.4%, mean duration of ulcer was 3 to 180 days .  
Out of 78 samples ,76 showed growth ,139 organisms were isolated ,an 
average of 1.8 organisms per lesion. Monomicrobial organisms were isolated 
34 samples which was 44.7%,rest were polymicrobial (55.3%). Most 
frequently isolated organisms were gram negative 93(69.4%) , followed by 
gram positive 41 (30.6%) . In gram positive organism Staphylococcus aureus 
were most commonly isolated, which was 28.4%. Only gram negative 
organisms were found in 14 cases (18.4%) ,had only gram positive in 35(46%) 
, remaining had  growth of both. 46 (49.5%) isolates of gram negative 
organisms showed  ESBL production, out of 19 isolates  of  Escherichia coli 
13 (68.3%) were ESBL producer, AmpC positive were 4(21.5%) , both ESBL 
and AmpC were 4(21.5%) .  
 Out of 28 isolates of Klebsiella, 12(42.9%) were ESBL producer, 
AmpC positive was 3(10.7%), both were ESBL and AmpC  3(10.7%) . Out of 
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32 isolates of Pseudomonas aeruginosa 13 (40.6%) were ESBL producer, 7 
(21.9%) were MBL positive , both were MBL and ESBL 7%(21.9%) positive . 
Out of 7 isolates of Acinetobacter species 5 (71.4%) were MBL positive, 
ESBL were not detected. Out of 38 isolates of Staphylococcus aureus MRSA 
was seen in 22 (57.9%) . 
Among the Staphylococcus aureus, high level resistance to Penicillin, 
Ampicillin, Erythromycin, Cotrimoxazole, Ciprofloxacin. Maximum 
sensitivity were seen to Netilmicin, Linezolid .Most of the gram negative 
organisms were resistant to various classes of antibiotics .Most effective 
antibiotic against gram negative organisms was Imipenem . 
Duration of  Diabetes mellitus showed borderline significant 
association with multi drug resistant organisms infection . Duration of diabetes 
increases , infection with multi drug resistant organism also increase . No 
significant association  of glycemic  control with MDRO and non MDRO 
infections . Duration of hospital stay increase with multi drug resistant 
organisms (MDRO) than non multi drug resistant organisms (NMDRO) 
.Infections with MDRO required significantly more surgical treatment than 
NMDRO. No significant association of glycemic control with MDRO and 
NMDRO .
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MATERIALS AND METHODS 
The study was conducted in a tertiary care hospital at Kulasekharam 
from June 2014 to August 2015. The study was approved by the Institutional 
Ethical and Research committee. A total of 75 specimens (pus, swabs, 
aspirated pus, debridement tissue) were collected from diabetic ulcer patients. 
The samples were collected in dressing room for out patients and in wards for 
inpatient and then immediately transported to the laboratory  and the 
specimens were processed without any delay. 
Inclusion criteria:  
 Patient admitted with clinically diagnosed diabetes mellitus, supported 
by laboratory findings and presented with ulcer. 
Exclusion criteria: 
• Patient with ulcers, who are not diabetic proved by clinical or 
laboratory investigations. 
• Gestational diabetes mellitus with ulcer. 
Sample collection: 
 The samples were collected according to the grade of ulcer. For 
superficial ulcer the wound was first rinsed with sterile saline and then pus 
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samples were collected by sterile cotton swab stick. Two swabs were 
collected, one for Gram stain and the another for culture. In case of  grade 2 or 
3diabetic ulcer,  the pus was aspirated in a 2ml sterile  syringe. If the diabetic 
ulcer is in grade 4 or 5, the pus was also collected in a 2ml sterile syringe. In 
case of patients undergoing surgery (debridement, amputations) tissues were 
collected and the specimens were processed without any delay.
70 
Gram staining: 
 Materials required for the test- 
• Gram stain kit (Hi media), which includes crystal violet, 
Grams iodine, acetone, safranin. 
• Glass slide. 
• Bacteriological wire loop. 
• Cedar wood oil. 
• Light Microscope. 
Procedure: 
              Gram stain was done for all the samples and the procedure handled 
was as follow: 
• Heat fixed smear of specimen stained with crystal violet for one minute. 
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• Grams iodine poured over the smear for one minute. 
• Smear was washed in a running tap water. 
• Decolourised with acetone for about 10 to 30 seconds. 
• Smear was washed with water and then counter stained with safranin 
for 30 seconds. 
• After drying the slides, a drop of cedar wood oil was placed over the 
smear and focused under light microscope at 100x oil immersion.
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Culture: 
Materials required: 
• Petri dish. 
• Bacteriological wire loop. 
• Nutrient agar (Hi media). 
• Mac conkey agar (Hi media). 
• Blood agar (Hi media). 
• Incubator. 
Media preparation for 100ml: 
Media                      100ml. 
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Nutrient agar            2.8gm. 
Mac conkey agar     5.1gm. 
Blood agar base      4.25gm. 
Nutrient agar (2.8 gm), Mac conkey agar (5.1gm), blood agar base 
(4.25gm) were mixed in a distilled water respectively and autoclaved at 121
0
C 
for 15 minutes and then medium was cooled to 52
0
C to reduce condensation of 
water on petri dish (For blood agar, 10ml of human blood [10% concentration] 
was added in the blood agar base medium) and then 14ml were poured in to 
90mm of diameter petri dishes, in a sterile laminar air flow cabinet. Dishes 
were left undisturbed until medium had set, labeled and then stored in 
refrigerator.
86 
Biochemical media preparation for 20ml: 
Media   20ml. 
• Peptone   0.3 gm. 
• Triple Sugar Iron 1.3 gm. 
• Mannitol   0.52 gm 
• Citrate   0.48 gm. 
• Urease   0.5gm. 
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        Peptone (0.3gm), triple sugar iron (1.3gm), mannitol (0.52gm), citrate 
(0.48gm), urease (0.5gm) media were mixed in 20ml of distilled water and 
autoclaved at 121
0
C for 15 minutes and then cooled to 52
0
C and then poured 
in the sterile test tubes in an volume of 4 to 5ml. Exceptmannitol, all the other 
media are slantingly placed and undisturbed until media had  set, labeled and 
then stored in refrigerator.
86 
Procedure: 
The swabs/ pus/ grounded tissue were inoculated on Nutrient agar, Mac 
conkeyagar, blood agar and incubated at 37
0
C for 18 to 24 hours. 
                The isolated colonies was identified by the standard biochemical 
tests such as: 
1. Triple sugar iron agar. 
2. Mannitol motility medium. 
3. Peptone water for indole production. 
4. Christensens urea media for urease test. 
5. Simmons citrate medium for citrate utilization test. 
6. Following carbohydrates were used for the biochemical test: 
Glucose, Lactose, Sucrose, Mannitol, Mannose (1% each). 
7. Following Deaminase test were carried out to identify the 
aminoacid fermentation.  
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Using readymade Hi media kit: 
a. Lysine decarboxylase. 
b. Arginine dihydrolase 
c. Ornithine decarboxylase. 
d. Control (without aminoacids). 
Procedure in detail: 
Two to three similar looking colonies from nutrient agar were picked 
up with loop and inoculated in the peptone water and then incubated for 2 to 4 
hours. And then inoculated into various biochemical test tubes under sterile 
precautions and then incubated at 37
0
C for 18 to 24 hours.
87 
1. Oxidative fermentative test: 
Used readymade OF medium (Hi Media), Liquid paraffin. Assessed 
aerobic, anerobic fermentation. 
Procedure:  
Tubes of medium are inoculated by stabbing, one tube is covered with 
layer of liquid paraffin to a depth of 5 to 10mm and both are incubated for 
upto 30 days.
87 
2. Nitrate reduction test: 
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Used nitrate broth (Hi Media),  
Test reagent : 
i) Solution A- Sulphanilic acid 
ii) Solution B- Alpha naphthylamine. 
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Procedure: 
            Inoculate the medium and incubate for 96 hours then add 0.1ml of 
solution A and B. The test assessed the reduction of nitrate.
87 
3. Phenylalanine deaminase test: 
Assessed the deamination of phenylalanine. Used Phenylalanine 
medium, 10% ferric choloride. 
Procedure: 
A medium containing phenylalanine is inoculated with growth of 
bacterial culture and incubated at 37
0
C for over night. A few drops of ferric 
choloride were added and then observed for any green colour change.
87 
4. Catalase test: 
Used 30% H2O2  for catalase test. 
Procedure: 
Four ml to 5ml of 30% hydrogen per oxide was taken in a test tube and 
then the colonies were picked up with sterile glass rod and inoculated in the 
hydrogen per oxide and observed for effervescence.
87 
5. Oxidase test: 
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Used ready made 1% oxidase disc (Hi media) (tetramethyl 
paraphenylene diamine dihydrochloride). 
Procedure: 
The discswereallowed to reach room temperature and placed over 
sterile petri dish and then moistened with distilled water and then colony to be 
tested was picked with glass rod from nutrient agar and smeared over the 
moist area. A positive reaction indicated by deep purple colour appearing 
within 5 to 10 seconds, maximum within 60 seconds.
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6. Antibiogram: 
i) Materials required for antibiogram: 
a. Muller Hinton agar. 
b. Antibiotic disc. 
ii) Media preparation (Muller Hinton agar for 100ml): 
Muller Hinton agar (3.8gm) (Hi media) was dissolved in 100ml of 
distilled water, then autoclaved at 121
0
C for 15 minutes and was cooled to 
52
0
C and then about 14ml was poured in the petri dish in a laminar air floor 
cabinet. Allowed to set, labeled  and then stored in the refrigerator.
86 
iii) Antibiotic disc used: 
              Disc    Symbol                   Microgram/ units 
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• Amoxicillin                      AX                             10 
• Cefalexin    PR                            30 
• Cefuroxime                      CB                            30 
• Cotrimoxazole      BA                            25 
• Ciprofloxacin                        RC                            5 
• Gentamicin                         GM                           10 
• Amikacin                              AK                            30 
• Netilmicin                             NT                            30 
• Ceftazidime                         FG                            30 
• Cefoperazone                     CP                             75 
• Cefotoxime                          CF                             30 
• Piperacillin                           PC                            100 
• Piperacillin/Tazobactam      PT                            100/10 
• Meropenem                         MP                            10 
• Penicillin                              PG                            10 
• Erythromycin                       ER                             15 
• Clindamycin                         CD                             2 
• Tetracyclin                           TE                              30 
• Vancomycin                         VA                              30 
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• Cefoxitin                               CK                              30 
• Novobiocin                            NV                              30 
iv) Preparation of McFarland standard 0.5 : 
0.05ml of 1% barium chloride and 9.95ml of 1% sulphuric acid was 
taken in a test tube, which corresponding to bacterial concentration of 10
8
CFU 
and  sealed and kept in a refrigerator.  
v) Procedure: 
            The organism grown aerobically wasinoculated in the peptone water 
and incubated at 37
0
C for 2 to 4 hours and the turbidity was tested against  
Mcfarland opacity tube 0.5 and from this growth, lawn culture was made on 
Muller Hinton agar plate and the appropriate antibiotic discs (based  on gram 
positive, gram negative) were placed and incubated at 37
0
C for 18 to 24 hours. 
The zone size around each antimicrobial disc was interpreted as sensitive or 
resistant according to CLSI guidelines.
88 
 Phenotypic screening of ESBL: 
Materials required for test: 
• Muller Hinton agar plate. 
• Antibiotic disc: 
• Ceftazidime-30microgram 
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• Ceftazidime/ Clavulanic acid- 30 microgram/ 
10microgram. 
• Cefotaxime- 30 microgram. 
• Cefotaxime / Clavulanic acid- 30microgram/  
10 microgram. 
Procedure: 
The organism grown aerobically inoculated in the peptone water and 
incubated at 37
0
C for 2 to 4 hours and the turbidity was tested against  
Mcfarland opacity tube 0.5 and from this growth lawn culture was made on 
Muller Hinton agar plate and the both ceftazidime and cefotaxime alone and in 
combination with clavulanic acid was performed for detection of extended 
spectrum beta lactamase (ESBL) among the family of Enterobacteriaceae. 
5mm or more than that increase in zone of inhibition for either ceftazidime/ 
clavulanic acid or cefotaxime/ clavulanic acid disc compared to 
ceftazidimeorcefotaximealonerespectively was taken as a confirmatory 
evidence of ESBL production. Quality control was performed using 
Escherichia coli ATCC 25922 for  ESBL detection.
2 
• MRSA screening: 
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Materials required: 
• Muller Hinton agar plate. 
• Cefoxitin disc (30microgram). 
 
Procedure: 
Staphylococcus species were tested for Methicillin resistance with 30 
microgram cefoxitin disc by Kirby Bauer disc diffusion method. Quality 
control was performed using ATCC Staphylococcus aureus 43300 was used 
for MRSA  detection, according to Natinal committee for clinical laboratory 
standard guidelines (CLSI 2011, volume-31, No-1) a zone of inhibition which 
was equal to or more than 22mm was considered as susceptible to cefoxitin 
and the organism was reported as Methicillin Sensitive Staphylococcus aureus. 
Those isolates produced zone on inhibition was equal of 21mm was 
considered as Methicillin resistant Staphylococcus aureus (MRSA).
84 
Statistics:   The data was collected and entered in a master chart. All the 
statistical calculations were done through SPSS (Statistical Presentation 
System Software). Analysis was done using Pearson chi square test, Fishers 
exact test. 
p value <0.05 is significant. 
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RESULTS 
Table: 1 DISTRIBUTION OF AGE 
Age Patients Percentage (%) 
41 to 50 8 11 
51 to 60 30 40 
61 to 70 30 40 
71 to 80 6 8 
81 to 90 1 1 
 
The age group varied from 41 to 90 years (Table 1) 
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Fig .1 Shows Distribution of Age in Percentage 
 
                               The age group varied from 41 to 90 years (fig:1) 
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Table: 2   DISTRIBUTION OF SEX 
Gender Patients Percentage (%) 
Male 57 76 
Female 18 24 
76% were males and 24% were females  (Table:2) 
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Fig .2 Distribution of Sex in Percentage 
 
76% were males and 24% were females (fig:2) 
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Table: 3   TYPES OF DM 
DM Patients 
Type 1 DM 8 
Type 2 DM 67 
 
Majority of the patients had type II DM (67%) (Table:3) 
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Fig.3 Type of DM 
 
Majority of the patients had type II DM (67%) (fig:3) 
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Table:4   DURATION OF DM 
 
DM Duration in years Patients Percentage (%) 
0 to 5 15 20 
6 to 10 31 41 
11 to 15 19 25 
16 to 20 6 8 
> 21 4 5 
 
Duration of DM varied from 6-15 years in a majority of patients studied (66%) 
(Table:4) 
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Fig. 4 Duration of DM 
 
 Duration of DM varied from 6-15 years in a majority of patients studied 
(66%) (fig:4) 
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Table: 5   HbA1C LEVEL 
DM HbA1c level Patients Percentage (%) 
Good control 6.3 to 7.3 10 13 
Fair control 7.4 to 7.9 2 3 
Poor control 8.0 to 9.3 46 61 
Uncontrol > 9.3 17 23 
 
The HbA1C level carried out on the patients showed a very poor 
control in the majority of  patients (61%). Screened which varied from 8 to 
9.3%. However the HbA1C level was uncontrollable (more than 9.3) in a large 
number of patients studied (23%) (Table:5) 
Table:5b. Distribution of HbA1C 
  
  
  
  
Neuropathy 
Yes No 
  
HbA1C 
Fair Control 4 7 
Poor Control 45 19 
 
P value of HbA1C is <0.05. Poor control of HbA1C level was 
associated with neuropathy, which is statistically significant (Table:5b). 
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Fig. 5 HbA1C Level 
 
   
The HbA1C level carried out on the patients showed a very poor 
control in the majority of  patients (61%). Screened which varied from 8 to 
9.3%. However the HbA1C level was uncontrollable (more than 9.3) in a large 
number of patients studied (23%) (fig:5) 
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Table:6    DISTRIBUTION OF SMOKERS AND NON SMOKERS 
Smoking Patients Percentage (%) 
Yes 53 71 
No 22 29 
 
The contributing factor like smoking was seen in 71% of the patients as 
shown in Table:6. 
Table:6(b) DISTRIBUTION OF SMOKING 
  
  
  
  
Neuropathy 
Yes No 
  
Smoking 
Yes 39 14 
No 10 12 
    Vasculopathy 
    Yes No 
Smoking 
  
Yes 4 49 
No 3 19 
p value of smoking is less than 0.05%. Smoking is associated with 
neuropathy, which is statistically significant. 
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Fig .6 Smokers & Non - Smokers 
 
  
The contributing factor like smoking was seen in 71% of the patients as 
shown in fig: 6 
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Table: 7 GRADE OF ULCER 
Grade  of Ulcer patients Percentage 
Grade 1 4 5 
Grade 2 14 19 
Grade 3 20 27 
Grade 4 32 43 
Grade 5 5 7 
 
Wagners grade 3,4 ulcers was seen in 70% of the studied group as 
showed in Table:7 
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Fig.7 Grade of Ulcer. 
 
 
Wagners grade 3,4 ulcers was seen in 70% of the studied group as showed in 
fig:7 
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Table: 8 DURATION OF ULCER. 
Duration of Ulcer Patients Percentage 
< 10 days 36 48 
11 to 20 days 11 15 
21 to 30 days 12 16 
31 to 60 days 12 16 
> 61 days 4 5 
 
Duration of ulcer was less than 10 days in a majority of patients (48%) 
as showed in Table:8 
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Fig. 8 Duration of Ulcer 
 
Duration of ulcer was less than 10 days in a majority of patients (48%) as 
showed   in fig:8 
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Fig.9  Distribution of Neuropathy 
 
Neuropathy was seen in 65% in the study population (fig:9) 
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Fig .10 Distribution of Vasculopathy 
 
 
 
Vasculopathy was seen in 23% in the study population (fig:10) 
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The predominant pathogens isolated were gram negative bacilli 
constituting 73.8% and gram positive cocci constituting 26.2%.  Among the 
gram negative bacilli Pseudomonas species was predominant having 36.2% 
incidence and among the gram positive cocci Staphylococcus aureus were the 
predominant pathogens accounting 42.8%. (fig:11) 
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Table:9 ANTIBIOGRAM 
  
PSEUDOMONAS SP KLEBSIELLA SP 
Sensitive 
Interme
diate Resistant Sensitive 
Interme
diate Resistant 
PENICILLIN - - - - - - 
AMOXYCILLIN - - - 0.00% 0.00% 100% 
TETRACYCLINE        
AMIKACIN 52.17% 8.69% 39.13% 69.23% 7.14% 30.76% 
PIPERACILLIM/TAZ
OBACTUM  68.42% 0.00% 31.58% 42.85% 21.42% 35.71% 
NETILMICIN  65.83% 15.38% 19.23% 78.57% 0.00% 21.43% 
PIPERACILLIN 28.57% 0.00% 71.43% 6.66% 22.66% 60% 
CIPROFLOXACIN  23.07% 0.00% 76.92% 25.25% 8.33% 66.66% 
COTRIMOXAZOLE     33.33% 0.00% 66.67% 
MEROPENEM  53.85% 0.00% 46.15% 90.91% 0.00% 9.09% 
GENTAMYCIN  24% 4% 72% 50% 0.00% 50% 
VANCOMYCIN  - - -    
CEFOLEXIN     20.00% 0.00% 80.00% 
CEFUROXIME     23.08% 7.69% 69.23% 
CEFOTOXIME  0.00% 0.00% 100.00% 21.43% 0.00% 78.57% 
CEFOPERAZONE 30.7% 7.69% 61.5% 20% 13.33% 66.66% 
CEFTAZIDIME  33.33% 5.56% 61.11% 20% 0.00% 80% 
Seventy four percent of Pseudomonas species was resistant to 3
rd
 
generation Cephalosporins. (Table:9) 
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Table:10 ANTIBIOGRAM 
  
PROTEUS  SPECIES E.COLI 
Sensitive 
Inter 
mediate Resistant Sensitive 
Inter 
mediate Resistant 
PENICILLIN - - -    
AMOXYCILLIN 21.42% 0.00% 78.57% 11% 0.00% 89.00% 
TEICOPLANIN - - - - - - 
CLINDAMYCIN - - - - - - 
ERYTHROMYCIN - - - - - - 
TETRACYCLINE  - - -    
AMIKACIN 64.28% 0.00% 35.71% 78% 0.00% 22% 
PIPERACILLIM/ 
TAZOBACTAM  86.66% 13.33% 0.00% 37.50% 0.00% 62.50% 
NETILMICIN  63.63% 0.00% 36.36% 86% 0.00% 14% 
PIPERACILLIN 63.64% 0.00% 36.36% 11% 0.00% 89% 
CIPROFLOXACIN  40% 13% 47.00% 33% 0.00% 67% 
COTRIMOXAZOLE  33% 0.00% 67% 50% - 50% 
MEROPENEM  84.62% 7.69% 7.69% 67% 22% 22% 
GENTAMICIN  53% 0.00% 47% 67% 0.00% 33% 
VANCOMYCIN  - - - - - - 
CEFOLEXIN  20% 0.00% 80% 22% 0.00% 78% 
CEFUROXIME  27% 0.00% 73% 33% 0.00% 67% 
CEFOTOXIME  30.77% 7.69% 61.54% 11% 0.00% 89% 
CEFOPERAZONE 35.71% 7.14% 57.14% 29% 0.00% 71% 
CEFTAZIDIME  53% 13.33% 33% 33% 0.00% 67% 
Table 10 shows Proteus species 87% sensitivity to Piperacillin/ 
Tazobactam, 85% to Meropenem and E.coli shows 89% resistant to 
Amoxicillin, Piperacillin, Cefotoxime. 
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Table: 11 ANTIBIOGRAM 
 
CITROBACTER SPECIES ENTEROBACTER SPECIES 
Sensitiv
e 
Inter 
mediate Resistant Sensitive 
Inter 
mediate Resistant 
AMOXYCILLIN 0.00% 0.00% 100.00% 100.00%   
TETRACYCLINE       
AMIKACIN 100% 0.00% 80.00%    
PIPERACILLIM/ 
TAZOBACTUM 17% 17% 67% 100.00%   
NETILMICIN 100% 0.00% 0.00% 100.00%   
PIPERACILLIN 20.00% 33% 67% 0.00% 100.00%  
CIPROFLOXACIN 50% 0.00% 50.00% 100.00%   
COTRIMOXAZOLE 83% 0.00% 73% 100.00%   
MEROPENEM 67% 0.00% 33% 100.00%   
GENTAMYCIN 25.00% 25.00% 50.00% 100.00%   
CEFOLEXIN 0.00% 0.00% 100.00% 100.00%   
CEFUROXIME 0.00% 0.00% 100.00% 100.00%   
CEFOTOXIME 0.00% 17% 83.00% 100.00%   
CEFOPERAZONE 17% 17% 67% 100.00%   
CEFTAZIDIME 17% 0.00% 83% 100.00%   
Table 11 shows Citrobacter and Enterobacter species shows 100% 
sensitivity to Netilmycin 
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Table:12 ANTIBIOGRAM 
 ACINETOBACTER SP 
 Sensitive Intermediate Resistant 
AMOXYCILLIN 0.00% 0.00% 100.00% 
AMIKACIN 40.00% 0.00% 60.00% 
PIPERACILLIM/TAZOBACTAM 0.00% 0.00% 100.00% 
NETILMICIN 40.00% 0.00% 60.00% 
PIPERACILLIN 0.00% 0.00% 100.00% 
CIPROFLOXACIN 0.00% 0.00% 100.00% 
COTRIMOXAZOLE 20.00% 40.00% 40.00% 
MEROPENEM 0.00% 0.00% 100.00% 
GENTAMICIN 0.00% 0.00% 100.00% 
CEFOLEXIN 0.00% 0.00% 100.00% 
CEFUROXIME 0.00% 0.00% 100.00% 
CEFOTOXIME 0.00% 0.00% 100.00% 
CEFOPERAZONE 0.00% 0.00% 100.00% 
CEFTAZIDIME 0.00% 0.00% 100.00% 
 
Table:12 shows Acinetobacter species 100% resistant to Amoxicillin, 
Piperacillin/Tazobactam, Piperacillin, Ciprofloxacin, Meropenem, 
Cefotoxime, Cefuroxime, Cefolexin, Gentamicin. 
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Table:13 ANTIBIOGRAM 
 
STAPHYLOCOCCUS  
AUREUS CONS 
Sensitive 
Inter 
mediate Resistant Sensitive 
Inter 
mediate Resistant 
PENICILLIN 9.00% 0.00% 91.00% 0.00% 17.00% 83.00% 
TEICOPLANIN 90.00% 10.00% 0.00% 80.00% 0.00% 20.00% 
CLINDAMYCIN 91.67% 0.00% 8.33% 60.00% 0.00% 40.00% 
ERYTHROMYCIN 15.38% 15.38% 69.23% 0.00% 0.00% 100.00% 
TETRACYCLINE 58.00% 17.00% 25.00% 50.00% 0.00% 50.00% 
AMIKACIN 63% 25% 12.5% 50.00% 16.67% 33.33% 
NETILMICIN 78% 0.00% 22% 60.00% 0.00% 40.00% 
CIPROFLOXACIN 33% 0.00% 67% 40.00% 0.00% 60.00% 
COTRIMOXAZOLE 18.00% 0.00% 81.00% 33.33% 0.00% 66.67% 
GENTAMICIN 40.00% 20.00% 40.00% 75.00% 0.00% 25.00% 
VANCOMYCIN 100.00% 0.00% 0.00% 100.00% 0.00% 0.00% 
NOVOBIOCIN 100.00% 0.00% 0.00% 100.00% 0.00% 0.00% 
CHOLORAM 
PHENICOL 100.00% 0.00% 0.00% 100.00% 0.00% 0.00% 
CEFOXITIN 83.33% 0.00% 16.67% 50.00% 0.00% 50.00% 
Eight one percentage of Staphylococcus aureus was resistant to 
cotrimaxozole in our  studyfollowed by Erythromycin (69%), Ciprofloxacin 
(67%), Gentamicin (40%). (Table:13). 
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Table:14     ANTIBIOGRAM 
 
 
STREPTOCOCCUS 
PYOGENES 
BETA - HEMOLYTIC 
STREPTOCOCCUS 
Sensitive 
Inter 
mediate 
Resistant Sensitive 
Inter 
mediate 
Resistant 
PENICILLIN 100.00% 0.00% 0.00% 100.00 0.00% 0.00% 
TETRACYCLINE 66.67% 0.00% 33.33% 50.00% 0.00% 50.00% 
AMIKACIN 75.00% 0.00% 25.00% 100.00% 0.00% 0.00% 
NETILMICIN 100.00% 0.00% 0.00% 100.00% 0.00% 0.00% 
CIPROFLOXACIN 75.00% 0.00% 25.00% 50.00% 0.00% 50.00% 
CEFUROXIME 100% 0.00% 0.00%    
CEFOTOXIME 100.00% 0.00% 0.00% 100.00% 0.00% 0.00% 
 
Streptococcus pygenes and other beta hemolytic streptococci were 
100% sensitive to penicillin (100%).  However Streptococcus pygenes was 
also  sensitive to Netilmicin, Cefotoxime and Cefuroxime(100%) as showed in 
Table:14. 
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Table:15 ANTIBIOGRAM 
  ENTEROCOCCUS SP STREPTOCOCCUS  SP 
  Sensitive 
Inter 
mediate Resistant Sensitive 
Inter 
mediate Resistant 
PENICILLIN    100.00%   
TETRACYCLINE  50.00% 0.00% 50.00% 50.00%  50.00% 
AMIKACIN 50.00% 0.00% 50.00% 100.00%  0.00% 
PIPERACILLIM/ 
TAZOBACTUM  - - -    
NETILMICIN  50.00% 0.00% 50.00% 100.00% 0.00% 0.00% 
PIPERACILLIN - - -    
CIPROFLOXACIN  100.00% 0.00% 0.00% 50.00% 0.00% 50.00% 
COTRIMOXAZOLE  50.00% 0.00% 50.00% 50.00% 0.00% 50.00% 
MEROPENEM  - - -    
GENTAMYCIN  - - -    
VANCOMYCIN  100.00% 0.00% 0.00% 100.00% 0.00% 0.00% 
CEFUROXIME  100.00% 0.00% 0.00%    
CEFOTOXIME  100.00% 0.00% 0.00%    
Table 15 shows Enterococcus species 100% sensitive to ciprofloxacin, 
cefotoxime, cefuroxime and  Vancomycin. 
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Fig. 12 List of organisms Producing ESBL 
 
Table: 16  ESBL. 
KLEBSIELLA SP 47% 
E.COLI 67% 
PSEUDOMONAS SP 15% 
PROTEUS  SP 13% 
CITROBACTER SP 17% 
 
Among the Gram negative bacilli 67% of E.coli and 47% of Klebsiella 
species were ESBL producers.  (Table:16) (fig:12) 
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DISCUSSION 
This study presents clinical and microbiological profile of  Diabetic 
foot ulcers. About 150 to 170 million populations are suffering from diabetes 
mellitusworldwide.
1
 In India nearly 40 million people are diabetics and their 
socioeconomic status is poor. Diabetic foot infections are seen in 20% of the 
patients and hence is the most commonly faced clinical problem. Ulcers 
treated in appropriately  may lead to amputation or disarticulation in varying 
levels atleast once in such patients life time.
62 
This study was carried out at SMIMS, Kulasekharamfrom June 2014 to 
August 2015. Samples (swabs, aspirated pus, debrided tissue) from 75 patients 
of diabetic foot ulcer was collected after receiving written consent from the 
patient.  
Majority of patients (80%) were in the age group of 51 to 70 years. 
Sixty  patients (93.3%) were suffering from type 2 diabetes mellitus. Rani.K.L 
et al 2013, Kaur.N et al 2014, Zubair.M 2010 also showed that type-2 diabetes 
was the predominating presentation of the patients suffering from diabetic foot 
ulcer.
71,78,58 
Duration of diabetes mellitus is also contributing factor for 
development of diabetic foot ulcer as seen in our study. Fourty six (76.7%) of 
the 60 patients in the age group of 51 to 70 years had 6 to 15 years of the 
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duration of diabetes mellitus. These patients may be immunocompromised due 
to age factor, type of diabetes mellitus and  are more prone for development of 
diabetes foot ulcer. The possibility of these  patients ending up in amputation 
is high, unless preventive measures are taken up at an early stage.Although the 
follow up of the patients could not be done in our study. The possibility of 
these patients developing complications are high due to their 
immunocompromised state. 
Majority of patients in our study had HbA1C level more than 8%, 
which showing poor control on diabetes mellitus. Fourty seven  (78.3%) of our 
patients in the  age group of 51 to 70 years had poor/ uncontrolled diabetes 
mellitus as evidenced by HBA1C levels. This also could be a contributing 
factor for subsequent development of complications, which may ultimately 
results in the amputation. Madanchi.N et al 2013,
76
 had also showed the 
association between HBA1C levels and development of complications. This 
was statistically significant in our study (p <0.05). 
Smoking can cause microvasculitis and diminish blood flow to the 
affected part. (Brike.J.A et al 1992)
11
. In our study majority of patients 71% 
were smokers of these 46 (76.6%) were ina age group of 51 to 70 years, 
majority of whom had developed complications and presented with Wagners 
grade 3 or grade 4 ulcers. 
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Poorly controlled diabetes leads to accumulation of these sugar 
products resulting in decrease in the synthesize of nerve cell, which required 
for normal neuron conduction and also depletion of nicotinamide adenine 
dinucleotide phosphate stores. There is a result in oxidative stress on the nerve 
cell and increase in vasoconstriction leading to ischaemia, which will promote 
nerve cell injury and death (Boring.C.K 2001)
89
. Fourty two (70%) of the 
patients in the age group of 51 to 70 years had associated neuropathy which 
increased the chances of developing ulcers. This has been the observation of 
Mohanasoundaram.K.M et al 2012.
90
On our study there was statistical 
significance of diabetic foot ulcer when compared with non smokers (p<0.05). 
Vasculopathy is one of the important contributing factor for 
development of diabetic foot ulcer as showed by Caputo.G.M et al 1994.
12
 
Sixteen (26.6%) of our patients who were in the age group of 51 to 70 had 
developed vasculopathy which must have contributed to the development of 
ulcer.  
The aerobic pathogens isolated were predominantly gram negative (79) 
followed by gram positive (28) bacteria (fig:11). Of these107, 70 gram 
negative bacilli and 20 gram positive cocci were isolated in the age group 
between 51 to 70 years. Of 70 gram negative bacilli isolated in the age group 
of 51 to 70 years, Pseudomonas species was the predominant isolate followed 
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by Klebsiella species, Proteus species, E.coli, Citrobacter species, 
Acinetobacter species and Enterobacter species. 
Among the gram positive cocci organisms isolated in this age group (51 
to 70years), Staphylococcus aureus was the predominant pathogen followed 
by coagulase negative Staphylococci, Streptococci pyogenes, other beta 
hemolytic Streptococci, Streptococcus species and only one Enterococcus 
species was isolated in this age group. A evidenced by Pappu.K et al, 
Shanmugam.P et al, also have shown the similar findings.
61,70 
In most of the infections in the age group between 51 to 70 years it was 
polymicrobial (31 cases), whereas monomicrobial etiology was seen in 27 
cases. As  alsoreported by Chopdekar.K.A et al 2011.
60
 There was no growth 
in two clinical samples this could be due to the prior antibiotic therapy before 
coming to the hospital or could be anerobic organisms the isolation of which 
was not attempted in the study. 
The antibiogram of the isolates showed that most of the Pseudomonas 
species was resistant to 3
rd
 generation Cephalosporins (74%) followed by 
Quinolones (76.9%)  and Aminoglycosides (72%) (Table:9). Twenty 
five(68.4%) isolates were sensitive to Piperacillin/Tazobactam followed by 
Netilmicin (65.8%) and Meropenem (53.8%). Shanmugam.P 2013 et al in 
their study also have shown, Pseudomonas being 50% resistant to Gentamicin 
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and Quinolones, 61% resistant to 3
rd
 generation Cephalosporin but 100% 
resistant to Meropenem. But in our study resistant to Meropenem was 46.2%. 
It is suprising to note that high amount  resistant to Meropenem which 
could be probably due to use of Carbapenems prescribed by general 
practitioners which must have resulted in developing resistance to 
Mereopenem before coming to our hospital. 
Klebsiella isolates were 100% resistant to Amoxicillin. Majoritry of 
them were also resistant to 3
rd
 generation Cephalosporin but 91% of the 
isolates were sensitive to Meropenem followed by Netilmicin(78.5%), 
Amikacin (69.2%), Gentamycin(50%).  
Majority of Proteus species showed sensitivity to Piperacillin / 
Tazabactam (86.7%) followed by Meropenem (84.6%). 
E.coli showed high amount of resistance to Amoxicillin, Cefotoxime, 
Piperacillin. However majority of orgainsms were sensitive to Netilmicin 
(86%), Amikacin (78%) followed by Gentamicin and Meropenem (67% each). 
Citrobacter species showed 100% resistant to Amoyxicillin, 
Cefuroxime, Cephalexin. However they were 100% sensitive to Amikacin and 
Netilmicin. 
Enterobacter species showed 100% sensitivity to most of the antibiotic 
used. 
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Acinetbacter species showed 100% resistant to Amoxicillin, all the 3
rd
 
generation Cephalosporins and Meropenem, Ciprofloxacin and Gentamicin. 
Only Amikacin and Netilmicin showed 40% sensitivity. 
Among gram positive organisms Staphylococcus aureus was the 
predominant pathogen and the antibiogram showed 100% sensitivity to 
Vancomycin, Choloramphenecol and Novabiocin followed by Clindamycin 
(91.7%) and Teicoplanin (90%). Of the total 18 Staphylococcus aureus, 2 were 
MRSA. Kaur.N et al 2014,
78
 also showed less sensitivity  to Clindamycin is 
contrast to our study. 
CONS showed a similar pattern of sensitivity to Vancomycin, 
Novobiocin, Choloramphenecol as Staphylococcus aureus. However they 
were less sensitive to Clindamycin (Table:13). One Coagulase negative 
Staphylococcus was resistant to Methicillin. Paul.S et al 2009,
56
 found that 
8.7% of Methicillin Resistant in their study. 
All the Streptococcus pyogens were sensitive to Penicillin, they were 
also 100%  sensitive to Netilmicin, Cefotoxime and Cefuroxime (Table:14)  
Enterococcus showed 100% sensitivity to Vancomycin, 
Cefuroxime,Cefotoxime. Ciprofloxacin seems to be good antibiotic  
fortreating infections with Enterococcus species, since they showed 100% 
sensitivity in our study. 
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Extended spectrum beta lactamase producing organisms were mainly 
seen in E.coli (67%), Klebsiella (47%). However ESBL was not a major 
problem in Pseudomonas species, Proteus species, Citrobacter species. 
However AmpC, MBL were not looked for  in our study (Table:16)(Fig:12). 
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SUMMARY 
 This  study helps the clinician to know the most common organisms 
causing foot ulcer infection and their  sensitivity pattern. 
 Polymicrobial  infections was dominant than monomicrobial 
infections. 
 Most common organisms causing diabetic foot infections were 
Pseudomonas species followed by Proteus species, Klebsiella species. 
In gram positive organism, Staphylococcus aureus was dominant 
followed by Streptococcus species. 
 Gram  negative organisms were highly sensitive to Netilmicin, 
Meropenem, Amikacin, Piperacillin/Tazobactam. 
 Gram positive organism was highly sensitive to Vancomycin, 
Netilmicin, Amikacin. 
 Gram negative organism was 100% resistant to Amoxicillin and highly 
resistant to 3
rd
 generation Cephalosporins and   Piperacillin. 
 Gram positive organisms were 100% resistant to Penicillin except 
Streptococcus pyogenes (100%  sensitivity). 
 Gram negative and Gram positive organisms were highly sensitive to 
Netilmicin (76% and 81%). Sensitive to Amikacinwas  (59% and 73%) 
and any one of them could be used as a monotherapy. 
 Most dominant ESBL producer in our study was E.coli. 
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 Methicillin Resistant Staphylococcus aureus  found in our study was 
16.66%. 
 Acinetobacter species were Multi Drug Resistant. 
 Most of the diabetic ulcer patients were smokers and diabetes was 
poorly controlled as evidenced by HBA1C levels leading to 
vasculopathy and neuropathy. 
 Statistical significance of  <0.05 was noticed in smokers and poorly 
controlled diabetes mellitus as evidenced by HBA1C levels leading to 
neuropathy and subsequent development of foot ulcers. 
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CONCLUSION 
 Diabetic foot ulcer infection should be treated according to culture and 
sensitivity  report. 
 To avoid unnecessary usage of antibiotic which may result in 
development of Multi Drug Resistant strains. 
 Emprical treatment should be based on recent report of articles of same 
geographical region. 
 Sensitivity pattern varies from place to place. This study could help 
clinician to know the sensitivity pattern of organism. 
 Diabetic foot ulcer treatment should  be based on multidisciplinary 
approach. 
 Smokers, poor controlled diabetes mellitus patients were more prone to 
develop foot ulcer infection. 
 It is health providers responsibility to enlighten the foot care in 
diabetes and consequences of foot infection and use of Proper foot 
wear which could decrease development of foot ulcer. 
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CONSENT FORM. 
PART 1 OF 2 
INFORMATION FOR PARTICIPANTS OF THE STUDY. 
 
Dear volunteers, 
             We welcome you and thank you for your keen interest in participation in this research 
project.Before you participate in this study,it is important for you to understand why this research 
is being carried out.This form will provide you all the relavant details of this research.It will 
explain the nature,the purpose,the benefits,the risks,the discomforts,the precautions and the 
information about how this project will be carried out.It is important that you read and understand 
the contents of the form carefully.This form may contain certain scientific terms and hence,if you 
have any doubts or if you want more information,you are free to ask the study personnel or the 
contact person mentioned below before you give consent and also at any time during the entire 
course of the project. 
 
  
       
 1.Name of the Investigator:     Dr.K. GREESH 
                                                                  Post graduate Student  
                                                                  Department of  Microbiology 
                                                                  SMIMS,Kulasekharam. 
  
 2.Name of the Guide:                             Dr.B.L. UMAPATHY. M.D 
                                                                   Associate Professor 
                                                                   Department of Microbiology, 
                                                                   SMIMS,Kulasekharam. 
 
  3.Name of the Co- Guide:                     Dr.U. ARUNACHALAM   M.S, Mch 
                                                                   Professor and Head  
                                                                   Department of Surgary 
                                                                   SMIMS,Kulasekharam. 
 
4. Insitute : .                                          Sri Mookambika Institute  of Medical Sciences, 
Kulasekharam,                                                            
Kanyakumari Dt,  
Tamil Nadu. 
 
  
 
 
5. Title of the study:  
Bacteriological Profile of diabetic foot among the patient attending Sree 
Mookambika Institute of Medical Sciences. 
6.Background information : 
 India has been labeled as diabetic capital of the world. Diabetic ulcer is one of 
the most feared complication of diabetes mellitus, many factors   like trauma, duration of 
diabetes, smoking and deformity can cause ulcer in diabetic patients.  
 The major factor which predisposed to the foot ulceration, which lead to the infected 
was usually related to peripheral neuropathy and an in impaired circulation which limited the 
access of the phagocytes.   
 Ones the protective layer of skin is broken, the deep tissue are exposed to bacterial 
colonization. Infection are facilitated by immunological deficits which are related to diabetes 
mellitus, and they rapidly progress to the deep tissue.   
 
7.Aims and objectives:  
The study will be carry out to determine the bacterial profiles of infected ulcers and 
the antibiotic sensitivity pattern of the isolates. 
 
8.Scientific justification of the study:  
There is paucity of data of bacteriological profile of diabetic ulcer at Sree Mookambika 
Insitiute of Medical Sciences. 
  
    
9. Procedure for the study.
 You are required to participate in this study only if you fully understand and agree to 
the requirements for the  same.  There will be no difference in the treatment you receive, nor 
will treatment be withhold. Based on your decision to participate in the study. The study is 
done in collaboration with department of Microbiology.  75 diabetic foot patients who 
volunteer are included in the study. After considering inclusion and exclusion criteria.  Swab 
or pus or debridement tissue will be collected from the diabetic foot ulcer patients. (IP &OP). 
  
 
 
  
 
   
The test kit is Hi Media Gram stain and source for culture plate is Hi Media. Your address, IP 
number, History of Illness, will be taken initially.
 10. Expected risks for the participants :   Moderate risk, individuals may develop 
 pain, bleeding. If any risk happens it would be treated as per hospital guidelines.  
11. Expected benefits of research for the participants : Susceptibility of mico 
organisms to antibiotics, which helps early diagnosis & cure and to prevent further 
complication. 
12. Maintenance of Confidentiality : All your study records will be kept confidential. 
Your personal  identity will not be revealed in any publication or release of results. Study 
records will be kept  indefinitely for analysis and follow up. 
13. Why have I been chosen to be in this study? To detect the organisms and its 
susceptibility to antibiotic, Which helps early diagnosis and treatment and to avoid further 
complication. 
14. How many people will be in the study?  75 
15. Agreement of Compensation to the participants (In case of a study 
related injury):  Any   adverse event as experienced due to the study will be treated as 
per hospital guidelines 
16. Anticipated prorated payment, if any, to the participant (s) of the 
study:  
      No 
17. Can I withdraw from the study at any time during the study period? 
Yes 
 
18. If there is any new finding / information ,would I be informed?  Yes 
 
  
 
 
19. Expected duration of the Participants participation in the study:  One 
Day 
20. Any other pertinent information: No 
21. Whom do I contact for further information? 
 
 
 
        
 
 
 
 
 
 
Place: 
 
Date:                                                                                               Signature of principal Investigator 
 
 
 
 
                                                                                                            Signature of the Participant. 
 
For any study related queries, you are free to contact 
                   Dr.K. GREESH 
                   Post graduate Student  
                   Department of  Microbiology 
                   SMIMS,Kulasekharam. 
                   Ph: 9566086742 
                   Email ID :  drgreeshk@gmail.com 
  
 
 
 
CONSENT FORM 
PART – II 
 The details of the study have been explained to me in writing and the details have 
been fully explained to me. I am aware that the results of the study may not be directly 
beneficial to me but will help in the advancement of medical sciences. I confirm that I have 
understood the study and had the opportunity to ask questions. I understand that my 
participation in the study is voluntary and that I am free to withdraw at any time, without 
giving any reason, without the medical care that will normally be provided by the hospital 
being affected. I agree not to restrict the use of any data or results that arise from this study 
provided such a use is only for scientific purpose(s). I have been given an information sheet 
giving details of the study. I fully consent to participate in the study titled” Bacteriological 
profile of diabetic foot ulcer among the patient attending Sree Mookambika Institute of 
Medical Sciences. 
 
Name :       Address : 
 
Hospital No : 
                                                                    Signature of the participant 
Witness 
1. 
2. 
 
Date : 
Place : Kulasekharam 
  
 
 
SREE MOOKAMBIKA INSTITUTE OF MEDICAL SCIENCES, 
KULASEKHARAM 
DEPARTMENT OF MICROBIOLOGY 
Proforma 
 
Study Title  : Bacteriological profile of diabetic foot among the patients attending 
             Sree  Mookambika Institute of Medical Sciences, Kulasekharam, 
Serial No   :            Date: 
 
Name    : 
 
Age  : 
 
Address : 
 
Contact No : 
 
Hospital Reference No:  
 
Type of diabetes: 
 
History of Diabetes mellitus and Treatment :  
 
Duration of Diabetes  : 
 
History of Hypertention / IHD/Dyslipidemia : 
 
Duration of foot ulcer: 
 
Antibiotic treatment: 
  
 
 
 
Foul smell: 
 
Crepitation: 
 
Purulent discharge: 
 
Vasculopathy: 
 
Neuropathy: 
 
Osteomyelitis: 
 
Cellulitis: 
 
Gangrene: 
 
Previous History of foot ulcer  :  
 
History of fever   :  
 
Smoking: 
 
Alcohol: 
 
Investigations:  
        Blood sugar level: 
        Foot X-ray if needed: 
 
 
 
 
